rfhg_27387.1

Basic information about the TSS

---

TSS ID: rfhg_27387.1 Species: human Chr: chr2		Start: 64653761 End: 64653843 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3133033,EH38E2003998)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC101641:64 GeneID: 9792 HGNC/MGI_ID: HGNC:30784 UniProt_ID: Nearer transcript ids and distances: BC101639:65 D50917:-69 ENST00000313349.3:-70 NM_014755.3:-70 AK311117:-73 BC074788:104 BC074789:104 view more...

Gene_name: SERTA domain containing 2 Gene_symbol: SERTAD2 Gene_synonyms: KIAA0127 Sei-2 TRIP-Br2 Gene_source: HGNC:30784

TATA-Box annotation

---

Distance to TSS:	111
Nearest PromoterID:	NM_014755
Entrez ID:	9792
Nearest Unigene:	Hs.591569
Nearest Refseq:	NM_014755
Nearest Ensembl:	ENSG00000179833
Gene Name:	SERTA domain containing 2
Gene Alias:	Sei-2|TRIP-Br2|TRIPBR2
Gene Type:	protein-coding
CpG%:	0.109756
GC%:	0.674699
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SERTAD2 p2@SERTAD2 p3@SERTAD2 p9@SERTAD2 p10@SERTAD2
Sample		p1@SERTAD2	p2@SERTAD2	p3@SERTAD2	p9@SERTAD2	p10@SERTAD2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	38.57	3.51	0.39	0.39	5.06
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	30.55	3.44	0.40	0.61	6.07
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	39.55	4.24	0.39	0.39	5.21
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	37.22	2.49	0.00	0.21	3.53
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	39.82	3.37	0.22	0.22	4.95
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	36.82	3.88	0.39	0.00	5.81
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	25.71	3.05	0.44	0.44	3.70
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	32.46	2.42	0.48	0.24	3.39
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	25.86	2.14	0.00	0.64	3.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	68.40	3.48	0.58	0.00	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	57.81	3.23	0.00	0.81	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	62.20	4.07	0.00	0.00	3.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	12.90	1.77	0.16	0.64	4.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.53	1.20	0.45	0.15	2.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	11.86	2.85	0.00	0.44	3.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.58	1.51	0.25	0.50	3.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.79	0.66	0.22	0.66	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.81	3.37	0.42	0.84	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.86	4.27	0.00	0.53	6.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	14.44	1.50	0.45	0.45	6.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	14.70	1.87	0.13	0.13	5.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	21.92	1.73	0.52	0.86	7.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	17.58	1.68	1.42	0.52	6.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	14.80	3.15	0.00	0.49	7.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	20.64	2.84	0.26	0.52	9.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	20.57	2.22	1.27	0.95	6.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	21.43	3.30	0.55	0.00	9.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	21.69	3.30	0.71	0.00	5.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	16.96	3.88	0.32	0.16	7.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.84	2.53	0.54	0.36	6.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.68	1.67	0.84	0.21	7.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	16.22	2.15	0.39	0.00	6.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	16.46	2.11	1.27	0.21	5.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	12.70	2.14	0.82	0.33	6.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	11.22	1.50	0.37	0.37	6.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	10.16	1.15	0.38	0.19	4.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.42	0.82	0.20	0.61	7.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.86	1.01	0.60	0.20	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.02	0.54	0.81	0.00	5.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	11.04	0.72	0.24	0.48	3.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.00	0.71	0.24	0.47	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	7.91	0.59	0.88	0.44	3.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	11.18	0.84	0.63	0.21	5.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.76	0.52	0.35	0.00	6.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.83	0.20	0.20	0.20	5.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	10.47	0.93	0.47	0.00	4.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	13.67	0.72	0.48	0.72	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	11.03	0.89	0.00	0.00	4.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	11.25	0.96	0.48	0.24	4.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	11.73	0.81	1.21	0.00	6.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	10.66	1.43	1.23	0.00	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	13.56	1.33	0.89	0.67	4.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	7.45	1.77	0.00	0.71	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	11.93	0.66	0.33	0.99	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.94	0.84	0.00	0.00	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	10.56	0.92	0.46	0.00	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.05	0.00	0.32	1.30	3.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.56	0.32	0.32	0.96	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	10.69	1.26	1.26	0.94	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.17	2.12	0.00	1.41	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.22	1.12	0.00	1.12	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.92	3.98	0.00	0.80	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.85	1.36	0.68	1.02	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.97	1.62	0.32	0.97	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.26	1.77	0.35	1.42	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	23.89	0.49	0.00	0.49	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	17.85	0.50	0.00	0.00	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	29.55	1.41	0.00	0.00	5.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.59	1.32	0.00	0.33	4.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	18.25	1.55	0.00	0.00	6.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	13.76	0.31	0.92	0.31	8.26
Adipocyte - breast, donor1	11376-118A8	25.82	1.43	0.79	0.32	2.38
Adipocyte - breast, donor2	11327-117E4	23.58	0.64	0.00	0.64	2.57
Adipocyte - omental, donor1	11473-119C6	28.75	3.69	0.76	0.25	3.31
Adipocyte - omental, donor2	11474-119C7	20.18	0.75	0.00	0.75	2.24
Adipocyte - omental, donor3	11475-119C8	24.78	0.33	0.00	0.00	2.34
Adipocyte - perirenal, donor1	11476-119C9	16.59	1.28	0.64	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	1.10	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	14.90	0.45	0.45	0.45	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	11.12	0.35	0.17	0.35	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	40.68	4.30	0.78	0.00	7.82
Adipocyte differentiation, day04, donor2	13022-139D7	45.04	3.09	0.77	0.00	3.09
Adipocyte differentiation, day04, donor3	13025-139E1	37.91	3.35	0.28	0.56	7.53
Adipocyte differentiation, day04, donor4	13028-139E4	37.62	2.35	0.59	0.00	8.82
Adipocyte differentiation, day08, donor1	13020-139D5	17.78	2.65	0.24	0.08	4.91
Adipocyte differentiation, day08, donor2	13023-139D8	27.76	3.55	0.65	0.00	6.13
Adipocyte differentiation, day08, donor3	13026-139E2	33.59	2.13	0.53	0.00	6.93
Adipocyte differentiation, day08, donor4	13029-139E5	11.13	2.23	0.00	0.00	6.68
Adipocyte differentiation, day12, donor1	13021-139D6	12.06	1.25	0.00	0.42	3.74
Adipocyte differentiation, day12, donor2	13024-139D9	17.33	1.76	0.50	0.00	4.52
Adipocyte differentiation, day12, donor3	13027-139E3	19.63	1.64	0.65	0.33	6.54
Adipocyte differentiation, day12, donor4	13030-139E6	7.92	0.91	0.30	0.00	3.35
Alveolar Epithelial Cells, donor1	11510-119G7	18.12	1.77	0.44	0.22	1.55
Alveolar Epithelial Cells, donor2	11590-120G6	10.76	1.08	0.00	0.36	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	1.20	0.00	0.00	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	25.19	2.16	0.18	0.18	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	5.02	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	15.41	1.44	0.62	0.21	2.05
Anulus Pulposus Cell, donor1	11248-116E6	24.94	2.86	0.00	0.00	6.18
Anulus Pulposus Cell, donor2	11463-119B5	23.27	2.45	0.24	0.00	2.69
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	7.64	1.80	0.00	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.95	0.43	0.00	0.00	3.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	10.46	2.69	0.00	0.30	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	0.00	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	10.56	1.98	0.00	0.00	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	8.12	0.97	0.32	0.00	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.19	1.94	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	9.50	1.19	0.00	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.42	2.26	0.00	0.75	2.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.89	1.45	0.00	0.00	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	2.51	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.68	2.14	0.00	0.00	1.81
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.94	1.66	0.00	0.30	1.66
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.00	4.82	0.54	0.00	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.07	2.08	0.19	0.19	2.65
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	12.03	2.67	0.00	0.27	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	1.95	0.00	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	6.80	1.00	0.33	0.17	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	0.00	0.00	0.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.92	2.23	0.51	0.34	3.09
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	7.77	5.34	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	5.69	1.90	0.38	0.00	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	3.99	1.14	0.00	0.00	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	6.41	1.71	0.21	0.21	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	7.23	1.03	0.52	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	9.38	0.47	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.97	1.29	0.32	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.85	0.71	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	4.09	2.92	0.00	1.17	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	7.83	1.51	0.00	0.00	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	9.50	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	6.61	2.54	0.00	0.51	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.91	1.27	0.00	0.25	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.17	0.64	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.77	1.73	0.00	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	8.89	1.69	0.21	0.00	1.69
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.54	0.58	0.29	0.29	3.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	1.89	0.00	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	9.32	1.19	0.00	0.17	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	2.32	0.00	2.32	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.22	1.50	0.00	0.21	2.14
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	9.63	3.61	0.00	0.60	2.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	4.37	2.19	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	10.34	2.30	0.00	0.46	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	2.55	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.85	1.53	0.25	0.25	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	9.50	2.68	0.00	0.21	2.06
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.90	3.37	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	5.74	1.91	0.00	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	8.43	1.55	0.22	0.44	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	3.05	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.08	1.66	0.00	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.80	1.85	0.26	0.53	2.65
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.00	2.54	0.36	0.00	1.82
Astrocyte - cerebellum, donor1	11500-119F6	36.72	2.58	0.12	0.25	2.46
Astrocyte - cerebellum, donor2	11580-120F5	36.29	2.23	0.34	0.34	2.57
Astrocyte - cerebellum, donor3	11661-122F5	18.88	1.26	0.00	0.00	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	15.34	2.79	0.00	0.35	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	17.80	2.10	0.00	0.00	5.18
Astrocyte - cerebral cortex, donor3	11392-118C6	21.33	1.79	0.00	0.45	3.73
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	65.03	4.59	0.92	0.11	31.77
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	52.87	5.51	0.25	0.00	36.58
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	49.50	4.89	0.46	0.00	35.39
Basophils, donor1	12241-129G9	163.72	43.41	0.26	0.52	9.42
Basophils, donor2	12242-129H1	138.18	49.79	0.00	0.36	10.82
Basophils, donor3	12243-129H2	102.90	33.07	0.15	0.73	7.35
Bronchial Epithelial Cell, donor1	11511-119G8	33.85	1.51	0.86	0.00	4.96
Bronchial Epithelial Cell, donor2	11591-120G7	11.89	0.46	0.91	0.00	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	5.02	1.88	0.63	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	8.94	1.04	1.04	0.42	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	10.59	1.38	0.69	0.23	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	28.61	1.80	0.36	0.00	4.86
Burkitt's lymphoma cell line:DAUDI	10422-106C8	51.94	6.39	0.41	0.10	10.61
Burkitt's lymphoma cell line:RAJI	10476-106I8	44.95	11.41	0.47	0.00	15.37
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	45.73	20.79	0.64	0.00	7.04
CD133+ stem cells - cord blood derived, pool1	12223-129E9	217.18	41.37	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	105.95	30.43	0.56	0.56	18.60
CD14+ Monocytes, donor2	11305-117B9	119.90	26.73	0.37	2.23	23.94
CD14+ Monocytes, donor3	11381-118B4	116.35	24.59	0.00	1.98	27.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	25.19	5.09	1.98	0.00	10.47
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	21.99	3.79	3.79	0.00	14.03
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	33.20	5.26	3.94	0.00	10.19
CD14+ monocytes - mock treated, donor1	11863-125A9	25.15	5.20	2.31	0.14	14.60
CD14+ monocytes - mock treated, donor2	11873-125C1	19.31	2.41	1.51	0.60	12.67
CD14+ monocytes - mock treated, donor3	11883-125D2	27.24	4.74	2.61	0.24	17.53
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	28.46	4.52	2.01	1.00	15.90
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	28.98	4.42	0.55	0.55	17.94
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	49.09	4.71	0.99	0.99	14.38
CD14+ monocytes - treated with BCG, donor1	11860-125A6	17.03	2.35	0.39	0.20	14.10
CD14+ monocytes - treated with BCG, donor2	11870-125B7	11.04	1.78	0.89	0.36	9.44
CD14+ monocytes - treated with BCG, donor3	11880-125C8	27.42	4.57	0.65	0.22	11.75
CD14+ monocytes - treated with Candida, donor1	11868-125B5	36.99	6.56	0.70	0.70	10.07
CD14+ monocytes - treated with Candida, donor2	11878-125C6	57.56	5.81	1.06	0.53	14.78
CD14+ monocytes - treated with Candida, donor3	11888-125D7	57.69	9.98	0.00	1.11	11.09
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	25.73	2.68	1.04	0.30	12.49
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	18.16	3.59	1.00	0.00	8.98
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	30.81	4.79	2.08	0.42	11.87
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	25.40	3.43	0.46	0.46	16.24
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	18.32	4.07	1.36	0.45	12.67
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	35.35	5.24	0.00	0.44	10.48
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	16.95	1.34	0.81	0.00	10.76
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	13.61	2.97	0.70	0.17	12.74
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	23.99	3.37	0.84	0.00	13.89
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	30.86	2.20	0.73	0.37	21.49
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	52.14	2.11	0.70	0.70	23.95
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	77.22	10.97	0.44	0.00	28.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	26.85	3.84	1.05	0.35	25.98
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	31.22	3.35	0.37	0.37	21.19
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	40.09	8.62	1.72	0.43	26.94
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	31.53	4.09	0.41	0.00	12.69
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	54.24	5.10	0.70	0.23	24.11
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	58.00	5.57	0.46	0.00	21.34
CD14+CD16+ Monocytes, donor1	11789-124B7	56.02	17.87	0.22	0.00	6.76
CD14+CD16+ Monocytes, donor2	11801-124D1	68.14	20.33	0.23	0.23	10.39
CD14+CD16+ Monocytes, donor3	11912-125G4	50.25	14.30	0.22	0.00	8.66
CD14+CD16- Monocytes, donor1	11788-124B6	103.24	30.05	1.09	0.00	13.39
CD14+CD16- Monocytes, donor2	11799-124C8	81.56	17.12	0.35	0.17	9.43
CD14+CD16- Monocytes, donor3	11910-125G2	170.13	40.36	1.56	0.00	15.61
CD14-CD16+ Monocytes, donor1	11790-124B8	55.37	17.10	0.51	0.26	9.19
CD14-CD16+ Monocytes, donor2	11800-124C9	55.55	15.81	0.00	0.00	5.71
CD14-CD16+ Monocytes, donor3	11911-125G3	66.53	14.32	0.21	0.21	4.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	42.68	18.29	0.00	0.00	8.13
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	60.34	14.92	0.00	0.00	8.81
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	77.67	11.39	0.00	1.04	8.28
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	79.96	17.59	0.00	0.00	14.39
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	76.66	9.65	0.00	0.00	5.90
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	70.19	8.42	0.00	0.00	7.72
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	65.89	10.98	0.00	0.00	10.20
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	73.82	10.55	0.00	0.00	9.23
CD19+ B Cells, donor1	11544-120B5	157.80	56.71	0.00	0.00	23.01
CD19+ B Cells, donor2	11624-122B4	89.95	42.80	0.00	0.00	10.88
CD19+ B Cells, donor3	11705-123B4	142.36	53.01	0.00	0.00	7.57
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	189.10	2.42	0.00	0.00	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	122.24	2.80	0.00	0.00	1.60
CD34+ Progenitors, donor1	11545-120B6	48.19	18.07	0.00	0.00	10.04
CD34+ Progenitors, donor2	11625-122B5	51.12	10.11	0.00	0.00	5.06
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	43.59	14.65	0.38	0.38	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	44.87	16.01	0.90	0.23	4.96
CD4+ T Cells, donor1	11225-116C1	53.92	39.99	0.36	0.36	6.07
CD4+ T Cells, donor2	11306-117C1	42.25	37.35	0.00	0.61	13.47
CD4+ T Cells, donor3	11382-118B5	53.68	34.16	0.00	0.30	9.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	14.55	5.36	0.00	0.00	8.17
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	19.76	6.96	0.00	0.22	8.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	25.58	8.62	0.00	0.00	8.34
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	43.62	17.07	0.47	0.47	5.69
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	41.44	8.43	0.00	0.70	9.13
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	13.18	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	14.74	5.20	0.00	0.00	7.08
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	10.85	3.73	0.51	0.17	4.24
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	12.57	6.77	0.00	0.00	7.42
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	26.00	13.00	0.00	0.00	2.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	27.25	11.88	0.00	0.00	5.24
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	34.76	21.12	0.00	0.00	4.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	40.90	10.54	0.00	0.00	10.12
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	43.84	6.86	0.83	0.00	16.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	29.07	5.35	0.00	0.33	17.37
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	51.67	24.47	0.27	0.00	7.34
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	66.99	24.12	0.00	0.00	5.90
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	73.52	21.52	0.00	0.00	7.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	17.99	9.46	0.00	0.00	3.34
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	13.00	4.55	0.43	0.00	2.60
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	14.29	5.04	0.00	0.00	3.78
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	27.81	15.17	0.00	0.00	6.57
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	23.83	10.40	0.00	1.30	4.77
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	35.30	21.35	0.00	0.00	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	37.12	9.90	0.49	0.00	7.92
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	32.31	9.23	0.00	0.00	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	16.75	2.79	0.00	0.00	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	52.62	11.63	0.55	0.00	3.05
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	51.78	13.50	0.49	0.00	3.44
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	35.42	10.78	0.00	0.00	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	35.45	8.95	0.00	0.00	8.95
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	36.01	8.31	0.00	0.00	5.54
CD8+ T Cells, donor1	11226-116C2	67.44	41.58	0.00	0.33	7.20
CD8+ T Cells, donor2	11307-117C2	56.31	34.54	0.00	0.75	9.76
CD8+ T Cells, donor3	11383-118B6	62.36	38.38	0.00	1.26	11.11
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	21.79	8.26	0.23	0.00	6.88
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	24.92	10.06	0.72	0.00	5.75
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	16.42	7.39	0.00	0.00	7.66
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	25.22	12.01	0.90	0.00	8.41
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	33.12	15.12	0.00	0.00	10.56
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	25.47	12.05	0.23	0.00	10.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	35.63	15.43	0.65	0.22	9.56
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	27.90	15.53	1.05	0.00	13.16
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	33.54	16.89	0.94	0.00	8.44
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	38.94	18.72	0.60	0.00	12.38
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	37.48	15.40	0.00	0.00	9.30
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	39.43	14.39	0.00	0.27	11.19
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	85.80	45.09	0.88	0.00	29.33
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	88.81	44.63	1.37	0.00	33.70
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	84.28	48.48	0.00	0.00	48.48
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	19.09	11.89	0.00	0.00	9.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	36.83	15.54	1.73	0.00	10.65
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	24.51	15.56	0.71	0.00	9.19
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	37.39	20.60	1.90	0.00	9.51
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	35.37	18.76	0.62	0.00	11.38
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	31.74	22.76	0.00	0.00	8.98
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	53.55	13.39	0.38	0.00	9.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	40.99	17.34	0.00	0.00	8.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	40.85	16.64	0.76	0.00	6.05
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	163.80	24.09	1.61	1.61	61.83
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	181.15	29.38	2.10	0.00	99.32
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	203.36	40.07	1.00	1.00	76.13
Cardiac Myocyte, donor1	11525-119I4	25.59	1.83	0.00	0.00	10.97
Cardiac Myocyte, donor2	11605-120I3	8.89	1.98	0.00	0.00	1.48
Cardiac Myocyte, donor3	11686-122I3	12.73	2.10	0.11	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	31.55	4.85	1.04	0.00	3.81
Chondrocyte - de diff, donor2	11338-117F6	28.43	1.07	0.00	0.71	2.13
Chondrocyte - de diff, donor3	11410-118E6	41.30	1.82	0.23	0.34	6.26
Chondrocyte - re diff, donor2	11339-117F7	44.76	5.37	0.90	0.00	6.27
Chondrocyte - re diff, donor3	11411-118E7	84.92	1.62	0.00	0.00	4.45
Ciliary Epithelial Cells, donor1	11242-116D9	37.64	3.56	0.57	0.46	5.51
Ciliary Epithelial Cells, donor2	11323-117D9	26.93	0.86	0.86	0.43	5.77
Ciliary Epithelial Cells, donor3	11399-118D4	21.33	3.10	0.27	0.18	4.69
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	22.47	7.34	1.19	0.00	8.89
Corneal Epithelial Cells, donor1	11526-119I5	21.30	2.20	0.88	0.00	2.20
Corneal Epithelial Cells, donor2	11606-120I4	37.54	1.14	1.14	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	27.35	1.53	1.53	0.00	3.07
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	10.07	3.80	5.28	0.00	8.09
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	13.88	3.78	1.89	0.00	4.10
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	0.00	3.45	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.56	4.32	1.51	0.00	4.21
Dendritic Cells - plasmacytoid, donor1	11228-116C4	296.89	68.67	1.02	0.34	2.73
Dendritic Cells - plasmacytoid, donor2	11309-117C4	239.60	73.77	0.65	0.65	3.26
Dendritic Cells - plasmacytoid, donor3	11385-118B8	303.92	87.11	0.48	0.00	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	5.34	3.17	0.33	0.00	1.67
Endothelial Cells - Aortic, donor1	11263-116G3	2.93	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	6.79	3.96	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	3.54	2.36	0.79	0.00	1.18
Endothelial Cells - Artery, donor1	11264-116G4	8.44	1.45	0.00	0.00	2.33
Endothelial Cells - Artery, donor2	11341-117F9	9.41	3.29	0.00	0.00	3.76
Endothelial Cells - Artery, donor3	11413-118E9	6.84	2.63	0.00	0.00	2.28
Endothelial Cells - Lymphatic, donor1	11236-116D3	7.31	3.10	1.11	0.00	3.99
Endothelial Cells - Lymphatic, donor2	11317-117D3	8.82	2.43	1.52	0.30	5.48
Endothelial Cells - Lymphatic, donor3	11393-118C7	12.40	7.05	0.28	0.00	3.95
Endothelial Cells - Microvascular, donor1	11265-116G5	16.94	2.97	0.59	0.00	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	15.10	1.04	0.00	0.00	3.64
Endothelial Cells - Microvascular, donor3	11414-118F1	9.22	3.26	0.00	0.00	3.83
Endothelial Cells - Thoracic, donor1	11266-116G6	10.40	2.80	0.00	0.00	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	5.24	3.14	0.52	0.00	4.19
Endothelial Cells - Umbilical vein, donor1	11243-116E1	9.57	6.09	0.50	0.00	3.98
Endothelial Cells - Umbilical vein, donor2	11324-117E1	3.48	3.69	0.43	0.00	2.39
Endothelial Cells - Umbilical vein, donor3	11400-118D5	6.11	3.54	0.24	0.00	4.15
Endothelial Cells - Vein, donor1	11267-116G7	4.55	3.41	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	2.79	1.40	0.00	0.00	2.10
Endothelial Cells - Vein, donor3	11416-118F3	1.88	1.73	0.16	0.00	2.04
Eosinophils, donor1	12244-129H3	76.23	0.00	0.00	0.00	30.49
Eosinophils, donor2	12245-129H4	316.85	110.57	0.00	0.00	14.85
Eosinophils, donor3	12246-129H5	260.38	92.74	0.00	0.00	14.27
Esophageal Epithelial Cells, donor1	11507-119G4	23.46	1.47	0.73	0.00	2.20
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	36.95	1.23	0.82	0.00	3.69
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.48	1.42	0.22	0.33	4.27
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	19.93	2.82	0.65	0.43	3.79
Fibroblast - Aortic Adventitial, donor1	11245-116E3	25.23	3.40	0.24	0.36	4.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	24.84	5.32	2.05	0.27	8.19
Fibroblast - Aortic Adventitial, donor2	11326-117E3	22.78	2.32	0.21	0.53	4.85
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	22.13	1.58	0.79	0.00	4.74
Fibroblast - Aortic Adventitial, donor3	11401-118D6	29.23	3.99	1.66	0.33	9.97
Fibroblast - Cardiac, donor1	11268-116G8	15.88	2.72	0.45	0.00	2.72
Fibroblast - Cardiac, donor2	11345-117G4	15.16	1.52	0.00	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	12.30	1.42	0.32	0.47	1.58
Fibroblast - Cardiac, donor4	11452-119A3	13.94	3.64	0.30	0.00	3.03
Fibroblast - Cardiac, donor5	11456-119A7	8.12	2.66	0.13	0.00	1.02
Fibroblast - Cardiac, donor6	11460-119B2	9.85	1.52	0.30	0.00	1.36
Fibroblast - Choroid Plexus, donor1	11492-119E7	11.12	1.88	0.13	0.13	1.07
Fibroblast - Choroid Plexus, donor2	11572-120E6	2.16	0.00	0.00	0.00	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	0.00	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	13.61	0.69	0.00	0.00	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	6.44	2.71	0.00	0.17	1.02
Fibroblast - Dermal, donor1	11269-116G9	12.44	1.64	0.23	0.00	6.10
Fibroblast - Dermal, donor2	11346-117G5	14.62	1.89	0.47	0.47	0.94
Fibroblast - Dermal, donor3	11418-118F5	13.90	1.93	0.73	0.12	4.35
Fibroblast - Dermal, donor4	11450-119A1	18.31	2.15	0.23	0.23	2.71
Fibroblast - Dermal, donor5	11454-119A5	19.71	1.92	0.00	0.17	3.14
Fibroblast - Dermal, donor6	11458-119A9	25.83	1.95	0.32	0.16	2.76
Fibroblast - Gingival, donor1	11237-116D4	6.46	0.83	0.42	0.00	2.08
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	26.20	1.57	0.52	0.79	7.07
Fibroblast - Gingival, donor2	11318-117D4	14.50	1.58	0.00	0.00	3.95
Fibroblast - Gingival, donor3	11394-118C8	8.51	1.26	0.00	0.00	3.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	25.97	1.04	0.00	0.00	6.23
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	23.44	1.94	0.35	0.35	2.64
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	23.54	3.43	0.47	0.31	3.12
Fibroblast - Gingival, donor6 (control)	11922-125H5	23.53	1.76	0.41	0.14	6.36
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	48.70	3.18	1.41	0.35	16.94
Fibroblast - Gingival, donor7 (control)	11924-125H7	25.30	1.32	0.00	0.44	6.43
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	22.91	3.27	0.27	0.55	6.54
Fibroblast - Gingival, donor8 (control)	11926-125H9	29.51	3.18	0.22	0.44	4.94
Fibroblast - Gingival, donor9 (control)	11927-125I1	27.15	2.05	0.59	0.73	6.90
Fibroblast - Lung, donor1	11270-116H1	5.44	2.72	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	11.94	1.49	0.00	0.00	5.97
Fibroblast - Lung, donor3	11419-118F6	6.12	1.27	0.42	0.00	2.32
Fibroblast - Lymphatic, donor1	11506-119G3	45.82	4.17	0.83	0.00	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	1.40	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	9.52	0.84	0.28	0.28	1.12
Fibroblast - Mammary, donor1	11540-120B1	24.36	1.22	1.22	0.00	2.03
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	9.70	0.58	0.00	0.00	2.72
Fibroblast - Periodontal Ligament, donor2	11319-117D5	19.42	1.67	0.00	0.15	5.16
Fibroblast - Periodontal Ligament, donor3	11395-118C9	14.38	0.92	0.31	0.00	4.59
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	32.06	1.91	0.38	0.00	4.58
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	22.68	2.43	0.00	0.00	3.78
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	24.12	2.09	0.23	0.12	4.29
Fibroblast - Pulmonary Artery, donor1	11250-116E8	11.83	2.10	0.22	0.22	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	20.12	3.45	0.00	0.00	1.22
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	6.01	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	8.70	1.19	0.40	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	56.56	3.37	0.60	1.19	3.37
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	41.21	1.42	0.36	0.18	3.37
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	55.78	2.76	1.18	0.20	7.10
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	35.80	1.50	1.50	0.00	3.31
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	49.33	5.51	1.30	0.43	6.59
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	28.34	2.28	1.01	0.25	1.52
Fibroblast - skin normal, donor1	11553-120C5	30.85	2.46	0.33	0.33	4.27
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	56.34	6.82	1.60	0.60	11.23
Fibroblast - skin normal, donor2	11561-120D4	78.16	5.22	1.11	0.80	4.82
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	36.87	1.51	0.30	0.60	2.72
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	39.02	2.07	0.58	0.25	6.96
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	24.27	1.88	0.17	0.00	3.59
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	31.53	3.94	0.99	0.66	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	58.48	4.58	1.38	0.64	5.11
Fibroblast - skin walker warburg, donor1	11554-120C6	36.94	2.87	0.67	0.17	3.71
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	23.05	2.98	0.78	0.31	4.08
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	22.16	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.09	6.97	4.36	0.00	16.56
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	10.05	3.12	0.87	0.17	1.21
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	17.18	2.08	0.78	0.00	3.12
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	13.80	2.81	1.02	0.00	1.79
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	6.12	1.53	0.00	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	7.02	1.28	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	8.27	2.28	0.00	0.00	3.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	33.09	7.17	0.83	0.55	3.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	19.86	3.42	0.68	0.00	12.33
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	6.54	1.39	0.59	0.20	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	26.96	3.97	0.26	0.26	5.02
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	19.57	2.94	0.33	0.33	6.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	7.96	1.33	0.00	0.00	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	12.44	1.27	0.14	0.14	2.69
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	12.93	1.72	0.00	0.12	3.20
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	7.52	1.61	0.00	0.00	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	14.00	1.12	0.00	0.25	3.96
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	12.87	2.21	0.00	0.00	2.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	8.95	0.81	0.20	0.00	3.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	16.20	0.91	0.23	0.00	4.34
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	8.84	1.37	0.12	0.00	3.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	13.99	0.87	0.00	0.00	4.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	22.46	2.36	0.59	0.00	8.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	14.62	2.07	0.00	0.00	1.91
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	16.31	2.01	0.00	0.00	3.57
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	22.78	3.02	0.40	0.20	5.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	15.95	2.04	0.00	0.17	4.24
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	25.18	3.72	0.44	0.09	7.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	38.81	6.14	0.62	0.00	8.74
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	36.72	4.78	0.85	0.00	6.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	16.82	2.21	0.22	0.00	3.76
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	23.63	2.33	0.50	0.08	4.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	25.73	2.86	0.20	0.20	4.29
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	26.61	3.30	0.21	0.00	7.84
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.18	2.77	0.00	0.12	4.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	19.01	2.84	0.17	0.17	4.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	20.94	1.98	0.44	0.22	6.39
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	23.37	1.72	0.37	0.12	4.92
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	23.83	2.76	0.16	0.32	6.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	30.47	2.89	0.64	0.00	11.87
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	16.96	2.18	0.19	0.09	6.06
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	17.08	1.90	0.47	0.32	6.96
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	30.41	3.34	0.91	0.30	6.69
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.71	2.61	0.10	0.42	5.02
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	15.81	1.76	0.44	0.00	9.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	23.85	1.68	0.00	0.28	7.29
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	19.72	4.35	0.28	0.19	5.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	9.63	2.94	0.00	0.00	4.28
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	22.49	3.52	0.77	0.15	5.51
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	12.69	1.68	0.13	0.39	4.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	11.93	1.90	0.27	0.00	5.69
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	23.23	4.06	0.74	0.74	8.85
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	31.58	5.04	0.66	0.88	7.68
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	43.64	4.96	1.98	0.00	17.85
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.55	2.64	0.66	0.53	5.67
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	28.85	4.84	0.00	0.20	8.88
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	73.20	13.72	2.54	0.25	21.86
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	9.36	2.39	0.00	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	8.32	0.92	0.00	0.00	2.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	11.87	2.66	0.20	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.32	0.31	0.00	0.31	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	4.24	0.85	0.28	0.00	1.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	11.53	0.46	0.00	0.00	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	8.90	1.16	0.00	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	8.02	3.21	0.00	0.00	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	5.22	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	11.72	0.98	0.00	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	16.47	1.24	0.00	0.41	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	6.66	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	18.46	0.56	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	13.07	0.98	0.33	0.00	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	24.33	2.52	0.00	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	23.86	1.91	0.00	0.00	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	11.89	2.04	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	0.00	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	32.07	0.00	0.57	0.00	5.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	10.95	0.59	0.59	0.00	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	5.08	3.39	1.69	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	23.61	2.49	0.41	0.00	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	20.71	2.76	0.46	0.00	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	10.54	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	19.99	1.54	0.00	0.00	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.39	0.98	0.33	0.00	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	11.37	2.01	0.00	0.00	10.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	27.35	1.54	0.39	0.00	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	22.25	3.42	0.34	0.00	3.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	2.48	0.00	0.00	14.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	29.73	0.47	0.00	0.00	7.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	29.57	0.60	0.00	0.00	8.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	21.87	2.03	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	27.12	2.79	0.00	0.00	3.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	22.69	2.47	0.00	0.00	5.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	44.86	2.36	0.00	0.00	11.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	31.51	2.33	0.00	0.00	5.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	35.55	0.44	0.44	0.00	9.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	47.47	3.39	0.00	0.85	10.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	31.64	3.58	0.00	0.60	6.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	15.53	2.43	0.00	0.00	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	73.04	0.00	0.00	1.14	4.57
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	61.54	1.66	0.42	0.00	10.81
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	30.36	0.00	0.00	1.12	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	36.79	2.22	0.00	0.32	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	9.61	1.25	0.42	0.42	2.92
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.75	1.16	0.00	0.12	1.62
Hep-2 cells mock treated, biol_rep2	11899-125E9	12.32	1.18	0.17	0.17	1.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	12.97	1.59	0.00	0.23	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	10.17	1.20	0.11	0.00	1.75
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	13.75	1.72	0.00	0.00	2.58
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	7.53	1.51	0.00	0.22	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	7.47	0.62	0.25	0.00	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.01	0.51	0.00	0.34	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.05	0.96	0.00	0.00	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	2.80	2.24	0.00	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	17.74	1.30	0.00	0.00	2.16
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	0.00	2.64	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.29	2.12	0.00	0.00	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	11.62	1.45	0.00	0.00	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	2.80	0.52	0.17	0.00	0.17
Hepatocyte, donor1	11523-119I2	15.74	1.21	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	11.85	4.31	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	10.43	1.84	0.00	0.00	6.14
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	14.36	3.26	0.00	0.00	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	42.47	4.72	0.00	0.00	4.02
Iris Pigment Epithelial Cells, donor1	11530-119I9	21.95	2.47	0.14	0.00	1.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	9.55	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	0.00	0.00	1.38	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	0.00	0.00	0.00	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	4.57	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	3.25	0.00	0.00	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	3.33	0.00	0.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	0.00	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	11.09	1.11	0.00	0.00	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	1.26	0.00	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	0.00	0.00	0.00	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.27	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	14.49	1.61	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	7.33	0.81	0.00	0.81	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	9.24	2.10	0.00	0.00	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.04	1.61	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	10.16	0.00	0.92	0.00	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	7.08	2.36	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	0.91	0.91	0.00	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	8.61	1.08	1.08	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	10.16	0.00	0.00	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	7.65	1.91	0.00	0.64	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	3.65	0.00	0.00	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.71	0.00	0.00	0.00	5.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.79	0.93	0.00	0.00	2.16
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	1.76	0.00	0.00	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	3.14	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	7.65	1.39	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	0.00	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	10.46	2.62	0.00	0.00	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	2.25	0.00	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	2.13	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	0.00	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	1.84	0.00	0.00	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	0.00	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	19.26	2.20	0.98	0.16	2.28
Keratinocyte - epidermal, donor2	11349-117G8	9.37	1.17	0.00	0.00	1.17
Keratinocyte - epidermal, donor3	11421-118F8	17.23	1.23	0.38	0.00	1.80
Keratinocyte - oral, donor1	11251-116E9	54.72	2.61	1.59	0.00	8.06
Keratocytes, donor1	11527-119I6	23.72	2.75	0.00	0.34	2.75
Keratocytes, donor2	11607-120I5	4.69	0.00	1.17	0.00	1.17
Keratocytes, donor3	11688-122I5	15.02	0.59	0.00	0.00	2.37
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	2.20	0.00	0.00	13.19
Lens Epithelial Cells, donor1	11529-119I8	28.05	2.16	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	21.80	1.85	0.12	0.00	2.42
Lens Epithelial Cells, donor3	11690-122I7	15.14	3.43	0.50	0.00	1.82
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.60	4.39	0.71	0.12	7.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	12.00	1.67	0.00	0.00	4.74
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.91	3.15	0.31	0.00	5.04
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	11.83	2.69	0.00	0.00	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.35	3.47	0.95	0.00	4.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.58	0.97	0.11	0.00	3.45
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	16.01	1.64	0.41	0.00	4.10
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	12.14	1.26	0.00	0.00	3.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.60	2.82	0.14	0.00	2.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	16.61	1.58	0.40	0.00	3.96
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	16.48	2.33	0.19	0.00	5.23
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.89	0.93	0.37	0.00	3.15
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.16	3.83	0.35	0.00	5.23
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	12.64	1.43	0.24	0.48	3.10
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.75	2.20	0.00	0.00	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	21.25	4.93	0.31	0.00	4.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.17	1.87	0.00	0.00	2.18
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.60	1.46	0.55	0.00	3.11
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	16.13	2.63	0.66	0.00	6.25
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.91	2.64	0.00	0.00	2.93
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.97	1.24	0.00	0.00	1.99
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	17.94	2.91	0.97	0.00	6.30
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.93	4.31	0.27	0.00	7.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.11	2.57	0.45	0.00	3.78
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.85	0.52	0.52	0.00	3.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	19.26	4.19	0.63	0.00	5.44
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.32	2.41	0.15	0.15	2.86
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	9.63	2.75	0.00	0.00	4.82
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	12.98	2.63	0.19	0.00	5.27
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.98	2.33	0.11	0.00	2.44
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	13.08	3.88	0.00	0.00	3.39
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.24	1.65	0.33	0.33	4.30
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.31	1.36	0.00	0.00	2.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.07	1.48	0.37	0.00	4.44
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	13.84	2.22	0.00	0.00	4.69
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.05	2.20	0.00	0.00	3.85
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.26	2.57	0.32	0.00	4.18
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	16.13	3.96	0.00	0.00	6.70
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.24	1.54	0.00	0.14	3.92
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	11.73	4.27	0.36	0.00	4.62
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.18	1.94	0.00	0.00	2.91
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.36	1.56	0.00	0.00	2.02
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.24	2.15	0.00	0.00	4.30
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	14.70	3.27	0.65	0.00	6.21
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.06	0.94	0.24	0.24	2.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.95	4.33	0.12	0.12	5.32
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.81	1.54	0.00	0.00	4.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.65	2.09	0.00	0.00	2.69
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	0.00	0.00	0.00	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	3.07	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	2.23	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	4.23	0.00	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	1.41	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.93	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	1.55	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	2.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	0.90	0.45	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	2.04	0.58	0.00	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	3.15	0.45	0.00	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	3.79	0.54	0.00	0.00	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	4.62	1.03	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	5.29	0.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	4.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.66	1.02	0.00	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	3.47	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	5.86	1.70	0.19	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.29	0.00	0.00	0.00	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	2.45	0.00	0.00	0.00	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	3.75	0.00	0.00	0.00	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	5.04	1.12	0.00	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	5.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	4.35	0.87	0.00	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	2.99	0.90	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	4.43	3.32	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	5.30	1.77	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	5.16	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	5.76	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	6.23	1.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	4.10	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	4.07	0.00	0.00	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.03	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	4.48	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	2.23	0.74	0.00	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.03	0.43	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	3.43	1.71	0.00	0.00	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	3.00	0.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	3.02	0.00	0.00	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2.13	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6.53	0.34	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	4.83	0.00	0.00	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	2.02	1.35	0.00	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	2.96	0.74	0.00	0.00	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	2.33	3.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	4.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	6.40	1.60	0.00	0.00	2.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	4.36	0.73	0.00	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	4.60	0.77	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	3.95	0.99	0.00	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.94	0.94	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	3.52	1.01	0.00	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	4.96	1.80	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	0.00	0.00	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	4.01	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	6.65	1.17	0.00	0.00	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.94	0.00	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	2.59	1.04	0.00	0.00	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	7.88	0.88	0.00	0.00	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	5.03	1.12	0.00	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	6.18	0.44	0.00	0.00	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.94	0.00	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.08	1.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	8.17	1.44	0.00	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	7.16	1.19	0.00	0.00	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	7.29	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.84	0.69	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	7.22	0.76	0.00	0.00	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	5.16	1.55	0.00	0.00	3.10
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.05	1.81	0.00	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	8.24	1.27	0.00	0.00	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.00	0.00	0.00	0.00	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	7.47	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	6.69	2.06	0.00	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	12.03	0.71	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	5.11	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	6.66	0.42	0.42	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	9.40	0.78	0.00	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.44	1.25	0.00	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	8.83	0.46	0.00	0.00	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	7.36	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	5.35	0.53	0.00	0.00	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	4.45	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	2.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	5.33	2.67	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	9.12	0.57	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.90	1.53	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	6.02	1.09	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	5.79	0.00	0.00	0.00	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	5.20	1.04	0.00	0.00	1.82
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	5.97	0.66	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	19.60	5.70	0.91	0.00	3.19
Macrophage - monocyte derived, donor2	11313-117C8	23.67	20.55	8.26	0.00	11.56
Macrophage - monocyte derived, donor3	11389-118C3	17.96	11.40	2.23	0.13	8.91
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	10.62	1.06	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	24.24	2.06	0.16	0.00	2.38
Mallassez-derived cells, donor3	11930-125I4	16.54	2.22	1.53	0.14	2.50
Mammary Epithelial Cell, donor1	11273-116H4	25.81	2.69	1.49	0.10	3.49
Mammary Epithelial Cell, donor2	11350-117G9	25.19	1.45	0.29	0.29	1.74
Mammary Epithelial Cell, donor3	11422-118F9	14.22	1.25	0.25	0.00	0.75
Mast cell - stimulated, donor1	11487-119E2	2.71	40.00	2.71	0.00	12.20
Mast cell, donor1	11563-120D6	21.41	10.81	0.32	0.11	3.24
Mast cell, donor2	11565-120D8	83.21	27.04	1.19	0.30	17.24
Mast cell, donor3	11566-120D9	77.67	28.14	1.80	0.23	19.36
Mast cell, donor4	11567-120E1	65.95	31.73	0.89	0.18	16.67
Mast cell, expanded and stimulated, donor5	11940-126A5	22.62	8.21	0.22	0.00	7.54
Mast cell, expanded and stimulated, donor8	11942-126A7	13.42	10.51	2.92	0.00	9.34
Mast cell, expanded, donor5	11939-126A4	19.73	7.23	0.11	0.00	2.41
Mast cell, expanded, donor8	11941-126A6	18.08	7.36	0.33	0.00	11.38
Melanocyte - dark, donor1	11502-119F8	9.85	3.38	0.00	0.10	3.98
Melanocyte - dark, donor2	11582-120F7	8.65	1.04	0.00	0.35	0.69
Melanocyte - dark, donor3	11663-122F7	29.92	2.32	0.00	0.00	1.09
Melanocyte - light, donor1	11274-116H5	35.73	3.53	0.47	0.00	6.58
Melanocyte - light, donor2	11351-117H1	11.60	1.36	0.00	0.68	1.36
Melanocyte - light, donor3	11423-118G1	11.27	0.00	0.87	0.00	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	28.43	1.56	0.10	0.21	1.87
Melanocyte, donor2 (MC+2)	12739-135I3	17.21	1.34	0.00	0.27	3.23
Melanocyte, donor3 (MC+3)	12837-137B2	36.70	3.48	0.00	0.00	3.48
Meningeal Cells, donor1	11493-119E8	15.38	1.98	0.00	0.12	0.74
Meningeal Cells, donor2	11573-120E7	3.52	0.44	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	9.70	0.41	0.08	0.00	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	32.79	3.42	0.00	0.57	9.12
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	16.91	3.12	0.50	0.10	8.45
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	0.00	1.31	0.00	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	0.00	0.00	0.72	2.87
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	9.32	1.91	0.21	0.21	1.91
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	8.04	0.50	0.00	0.00	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	38.68	1.54	0.44	0.00	6.15
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	61.37	2.19	2.19	0.00	10.96
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	26.60	3.07	0.61	0.20	7.37
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	23.13	1.11	0.14	0.00	2.08
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.20	1.49	0.00	0.37	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.82	1.32	0.00	0.00	1.32
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.93	0.89	0.00	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	2.34	0.00	0.00	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.89	0.64	0.00	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	15.95	2.13	0.35	0.00	1.77
Mesenchymal stem cells - hepatic, donor0	11218-116B3	6.25	1.25	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	14.51	1.45	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	9.55	2.12	0.00	0.27	2.65
Mesothelial Cells, donor2	12156-128G5	8.51	0.00	0.00	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	12.72	1.73	0.29	0.14	1.73
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	10.80	5.40	0.00	40.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	18.47	11.33	3.45	0.00	9.85
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	14.13	12.66	2.94	0.00	16.20
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	6.91	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.54	7.44	2.48	0.00	8.37
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.13	7.68	2.07	0.00	12.24
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	9.26	0.00	0.00	20.84
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	16.27	9.01	2.00	0.00	10.76
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.50	7.45	1.86	0.00	15.36
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	38.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	16.05	11.58	3.05	0.00	7.72
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.46	8.71	1.98	0.00	14.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	17.10	0.00	0.00	17.10
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	24.78	5.31	0.88	0.00	6.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	12.92	11.40	2.66	0.00	13.30
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	5.26	1.32	0.00	6.58
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	21.86	7.85	0.64	0.00	8.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	3.68	0.00	0.00	20.26
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	23.25	8.05	0.30	0.00	10.73
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	0.00	1.68	0.00	8.38
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.56	4.52	1.00	0.00	7.28
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.18	3.09	2.14	0.00	12.36
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.08	1.66	0.00	0.00	8.29
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.97	3.68	0.69	0.00	6.91
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.21	2.52	1.47	0.00	10.31
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.38	2.85	1.22	0.20	9.17
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.52	3.22	0.64	0.00	8.15
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.22	2.22	0.44	0.00	10.23
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.27	4.60	0.44	0.00	5.04
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3.55	3.04	2.03	0.00	15.21
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	3.31	0.00	0.00	9.94
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	15.76	3.26	0.27	0.27	7.07
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.06	4.71	0.88	0.00	10.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	3.27	0.00	0.00	6.54
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.97	1.44	0.48	0.00	4.81
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.41	4.80	1.20	0.00	8.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	5.48	0.00	0.00	6.86
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.02	4.00	0.50	0.00	6.51
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	2.04	0.00	0.00	14.27
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.89	3.50	0.00	0.00	6.13
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	6.62	0.00	0.00	11.04
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	3.20	0.00	0.00	10.25
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	19.09	4.96	1.49	0.00	7.19
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.26	3.48	0.00	0.00	9.74
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	0.00	0.00	11.05
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	14.36	4.10	0.68	0.00	2.74
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.00	4.81	0.00	0.00	9.63
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	4.62	2.49	0.36	0.00	8.17
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	14.59	1.40	1.12	0.00	6.73
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.98	2.91	0.83	0.00	5.82
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.33	3.50	0.00	0.00	6.99
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.08	1.51	0.00	0.00	3.62
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.43	3.34	2.09	0.00	8.77
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	13.85	3.69	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	12.52	7.97	0.57	0.00	7.97
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	9.95	1.93	0.28	0.14	4.42
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	14.77	1.81	0.26	0.00	2.59
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	11.58	3.43	1.29	0.00	9.01
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.35	2.54	0.64	0.00	5.08
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.88	1.87	0.27	0.00	2.67
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	25.74	11.37	1.80	0.00	10.78
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	14.55	3.11	0.28	0.00	5.09
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	20.07	4.14	0.64	0.00	4.78
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	16.36	4.64	1.55	0.00	7.74
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.34	1.52	0.00	0.00	5.31
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	18.18	1.70	0.28	0.28	4.55
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	16.96	3.20	0.98	0.00	6.15
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.87	3.26	0.00	0.00	6.52
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.17	5.00	0.29	0.00	4.70
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	24.22	5.48	0.86	0.00	8.65
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	24.73	11.95	3.30	0.00	11.54
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	19.65	4.47	0.89	0.00	5.06
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	15.44	2.30	0.66	0.00	3.94
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	4.21	7.36	1.05	0.00	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	14.43	5.93	0.79	0.00	6.72
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	19.56	5.59	0.93	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	11.64	7.14	0.00	0.00	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	16.51	8.79	0.53	0.00	7.46
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	16.74	3.73	0.34	0.00	3.28
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	15.47	3.68	0.00	0.74	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	14.29	3.30	0.37	0.00	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	6.22	0.00	0.00	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	9.09	2.67	0.00	0.00	2.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	3.86	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	20.20	1.01	0.00	0.00	5.05
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.70	5.48	0.42	0.00	8.01
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	23.15	8.17	2.72	0.00	8.17
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	0.64	0.64	0.00	5.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.81	0.00	0.00	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	3.02	3.02	0.00	15.10
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	28.55	0.00	0.00	62.81
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	45.67	6.52	0.00	75.04
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	61.78	19.01	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.00	1.29	0.00	0.22	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	12.02	2.09	0.52	0.00	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.68	2.67	0.67	0.00	19.36
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	19.62	0.83	0.83	0.00	41.32
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	19.20	5.13	2.28	0.57	30.23
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	1.60	1.60	0.00	49.47
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.92	4.08	0.00	0.00	36.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	31.24	1.84	0.00	0.00	14.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.63	2.09	0.42	0.42	14.65
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	15.81	1.86	0.70	0.70	24.64
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.05	1.89	1.08	0.27	24.86
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	39.10	3.78	1.05	0.63	37.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	17.37	0.00	0.50	0.50	24.32
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.91	2.17	0.54	0.00	20.30
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	11.56	0.45	0.45	0.68	20.85
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	17.47	0.65	0.33	0.49	25.64
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	30.25	2.37	0.73	0.55	30.25
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	20.16	1.59	0.00	0.53	24.93
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.01	0.60	0.60	0.00	39.62
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.72	4.27	0.98	0.00	26.91
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.38	1.63	0.16	0.33	21.47
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	32.98	2.82	1.59	0.18	41.98
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	0.00	0.00	1.41	18.28
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.63	1.38	1.38	0.00	41.83
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	17.67	2.25	0.00	0.00	23.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	16.21	3.10	1.38	0.34	17.24
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	65.74	2.53	2.53	0.00	30.34
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	30.08	2.67	0.22	0.22	29.63
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.94	2.12	0.85	0.42	30.06
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	19.46	1.90	0.47	0.00	32.52
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	20.17	1.29	1.29	0.00	31.34
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	9.03	0.00	0.00	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	20.66	2.00	1.67	0.00	22.66
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	26.60	3.16	2.71	0.45	28.40
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.49	2.38	0.00	0.79	12.70
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	24.14	2.79	0.00	0.00	20.43
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	12.86	1.14	0.76	0.38	26.49
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	18.58	0.98	0.65	0.33	10.43
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	21.79	0.44	0.44	0.00	39.22
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	25.78	1.81	0.45	0.45	29.40
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	19.40	0.00	0.00	0.88	12.35
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	21.94	1.99	1.33	0.00	28.59
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	17.36	0.99	0.00	0.00	29.76
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.93	2.68	0.00	0.00	23.74
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	24.80	0.91	0.60	0.60	32.66
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	38.02	2.65	0.44	0.22	20.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	11.52	1.36	0.00	0.00	10.16
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	5.11	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.80	1.22	1.22	1.83	20.73
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.53	0.94	0.63	0.00	19.51
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.65	0.61	1.51	0.00	62.95
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	29.27	0.79	0.00	2.37	16.61
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	31.74	4.53	3.40	0.00	21.54
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	0.00	0.00	0.00	25.29
Myoblast, donor1	11241-116D8	21.99	1.86	0.75	0.12	5.09
Myoblast, donor2	11322-117D8	22.44	3.26	0.96	0.19	12.27
Myoblast, donor3	11398-118D3	45.74	4.37	1.35	0.67	7.40
NK T cell leukemia cell line:KHYG-1	10777-110G3	18.83	4.82	0.00	0.00	7.59
Natural Killer Cells, donor1	11230-116C6	87.03	44.28	0.00	0.62	10.15
Natural Killer Cells, donor2	11311-117C6	85.34	48.25	0.30	0.00	10.86
Natural Killer Cells, donor3	11387-118C1	84.66	37.18	0.00	1.47	9.39
Neural stem cells, donor1	11275-116H6	13.43	2.90	1.09	0.00	2.90
Neural stem cells, donor2	11352-117H2	38.51	1.93	0.00	0.00	3.85
Neurons, donor1	11494-119E9	11.38	2.28	0.00	0.00	1.14
Neurons, donor2	11574-120E8	8.37	0.88	0.00	0.00	0.88
Neurons, donor3	11655-122E8	9.87	0.00	0.00	0.82	3.29
Neutrophils, donor1	11233-116C9	232.93	69.60	0.93	0.00	7.42
Neutrophils, donor2	11314-117C9	147.84	43.48	0.00	0.00	8.70
Neutrophils, donor3	11390-118C4	358.56	93.46	0.61	0.00	10.38
Nucleus Pulposus Cell, donor1	11252-116F1	31.70	4.27	0.36	0.12	9.38
Nucleus Pulposus Cell, donor2	11409-118E5	14.65	1.95	0.33	0.00	7.16
Nucleus Pulposus Cell, donor3	11462-119B4	21.06	1.60	0.00	0.40	2.01
Olfactory epithelial cells, donor1	11933-125I7	10.74	0.55	0.14	0.28	2.75
Olfactory epithelial cells, donor2	11934-125I8	18.24	2.75	0.43	0.29	5.93
Olfactory epithelial cells, donor3	11935-125I9	9.87	1.02	0.57	0.11	2.38
Olfactory epithelial cells, donor4	11936-126A1	26.20	1.95	0.19	0.39	7.21
Oligodendrocyte - precursors, donor1	11496-119F2	13.84	1.81	0.00	0.00	2.41
Osteoblast - differentiated, donor1	11276-116H7	20.21	2.77	0.85	0.00	8.08
Osteoblast - differentiated, donor2	11353-117H3	18.29	0.00	0.00	0.00	6.86
Osteoblast - differentiated, donor3	11425-118G3	14.28	0.62	0.00	0.00	6.21
Osteoblast, donor1	11277-116H8	9.38	0.39	0.59	0.00	3.91
Osteoblast, donor2	11354-117H4	58.99	4.92	0.00	0.70	9.13
Osteoblast, donor3	11426-118G4	36.08	3.38	0.18	0.36	6.40
Pancreatic stromal cells, donor1	11249-116E7	11.37	2.44	0.25	0.00	5.22
Pericytes, donor1	11491-119E6	11.35	1.34	0.22	0.00	2.11
Pericytes, donor2	11571-120E5	10.87	1.13	0.00	0.23	1.36
Pericytes, donor3	11652-122E5	12.21	1.22	0.00	0.00	0.61
Perineurial Cells, donor1	11499-119F5	14.69	1.36	0.00	0.00	1.92
Perineurial Cells, donor2	11579-120F4	10.03	3.59	0.18	0.09	0.74
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	124.63	44.62	0.32	0.32	11.79
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	111.41	30.12	0.73	0.00	17.87
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	86.84	34.42	0.52	0.13	9.19
Placental Epithelial Cells, donor1	11278-116H9	15.31	1.20	0.00	0.24	0.96
Placental Epithelial Cells, donor2	11355-117H5	9.98	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	14.14	0.59	0.00	0.00	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	33.54	1.90	0.32	0.32	1.90
Preadipocyte - breast, donor1	11467-119B9	30.58	2.81	0.56	0.00	2.06
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	26.50	1.96	1.04	0.13	1.44
Preadipocyte - breast, donor2	11328-117E5	33.77	2.03	0.90	0.00	2.70
Preadipocyte - omental, donor1	11468-119C1	32.93	2.24	1.17	0.75	3.94
Preadipocyte - omental, donor2	11329-117E6	35.35	2.62	0.87	0.44	2.62
Preadipocyte - omental, donor3	11403-118D8	29.51	3.01	0.29	0.14	4.30
Preadipocyte - perirenal, donor1	11469-119C2	14.76	0.98	0.00	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.98	3.38	0.31	0.00	5.84
Preadipocyte - subcutaneous, donor2	11356-117H6	29.57	2.83	0.35	0.18	9.03
Preadipocyte - subcutaneous, donor3	11428-118G6	20.26	2.38	0.68	0.00	7.15
Preadipocyte - visceral, donor1	11280-116I2	52.44	4.10	1.77	0.19	15.93
Preadipocyte - visceral, donor2	11357-117H7	17.95	0.92	0.46	0.00	6.90
Preadipocyte - visceral, donor3	11429-118G7	31.87	2.30	1.25	0.21	9.20
Prostate Epithelial Cells (polarized), donor1	11253-116F2	30.77	3.77	0.00	0.15	1.96
Prostate Epithelial Cells, donor2	11331-117E8	12.19	0.95	0.14	0.14	2.17
Prostate Epithelial Cells, donor3	11404-118D9	19.84	1.04	0.12	0.00	5.63
Prostate Stromal Cells, donor1	11254-116F3	12.98	2.62	0.00	0.00	2.96
Prostate Stromal Cells, donor2	11332-117E9	17.57	1.97	0.54	0.00	3.05
Prostate Stromal Cells, donor3	11405-118E1	16.48	1.98	0.52	0.10	3.34
Renal Cortical Epithelial Cells, donor1	11516-119H4	29.93	0.73	0.36	0.73	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	29.60	1.52	0.00	0.42	1.73
Renal Epithelial Cells, donor1	11517-119H5	23.33	0.00	0.00	0.00	1.52
Renal Epithelial Cells, donor2	11597-120H4	19.92	3.56	0.00	0.00	3.56
Renal Epithelial Cells, donor3	11678-122H4	27.52	1.91	0.00	0.21	1.48
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	3.40	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.41	2.16	0.27	0.00	1.89
Renal Glomerular Endothelial Cells, donor3	11675-122H1	17.98	2.44	0.22	0.22	1.78
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.66	2.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	14.31	1.10	0.00	0.00	1.32
Renal Mesangial Cells, donor2	11598-120H5	22.57	1.25	0.00	0.00	4.39
Renal Mesangial Cells, donor3	11679-122H5	9.71	1.39	0.28	0.00	2.50
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	40.80	1.88	0.00	0.27	2.95
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.49	1.27	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	24.11	2.12	0.00	0.77	2.89
Retinal Pigment Epithelial Cells, donor0	11215-116A9	17.37	0.78	0.00	0.00	1.56
Retinal Pigment Epithelial Cells, donor1	11528-119I7	21.89	2.56	0.00	0.57	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	11.32	0.00	1.03	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	11.04	1.25	0.00	0.50	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	38.75	4.01	0.53	0.27	12.29
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	42.88	2.68	0.00	1.79	8.93
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	55.59	3.30	1.10	1.65	11.01
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	57.43	4.64	1.16	0.58	12.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	75.02	4.55	0.65	1.04	4.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	53.72	2.28	0.79	2.48	11.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	55.88	3.46	0.56	0.89	7.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	63.26	3.35	0.62	1.98	5.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	60.25	3.61	0.23	2.33	9.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	63.56	4.62	0.92	1.16	10.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	59.97	2.05	0.41	1.78	7.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	57.94	3.93	0.45	1.82	11.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	53.22	3.23	0.54	0.90	8.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	62.83	4.16	0.29	2.73	4.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	56.88	4.51	0.43	1.40	9.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	48.02	3.54	0.66	2.21	7.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	63.28	3.63	0.76	1.72	5.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	49.75	3.07	0.09	1.02	10.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	69.34	5.07	0.56	2.25	12.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	61.05	4.51	0.66	1.86	6.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	62.49	4.58	0.58	2.24	11.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	47.55	4.01	0.76	2.67	12.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	71.34	3.74	0.32	1.71	6.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	62.51	5.05	0.28	1.68	10.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	51.61	2.73	0.85	1.37	11.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	64.00	2.92	0.73	2.01	9.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	57.76	2.94	0.49	1.96	8.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	46.21	2.69	0.27	1.34	8.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	85.39	3.30	0.47	2.59	6.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	65.08	3.97	0.60	2.58	11.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	49.11	1.87	0.23	1.40	10.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	69.26	2.90	0.83	2.49	6.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	57.74	5.53	0.44	2.43	9.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	41.57	3.34	0.21	1.67	13.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	78.19	4.17	0.94	2.29	6.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	52.62	6.30	1.53	0.68	16.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	50.13	3.08	0.77	2.12	11.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	78.40	4.81	0.69	1.55	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	56.93	5.21	0.69	0.82	11.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	59.76	4.27	0.33	0.49	15.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	60.84	3.92	0.51	2.22	6.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	55.04	3.99	0.44	1.33	9.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	62.64	6.40	1.33	0.80	13.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	57.24	4.29	0.28	0.41	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	40.00	2.14	0.48	0.48	7.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	72.35	6.05	0.40	1.21	19.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	52.64	3.30	0.00	0.75	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	56.60	3.84	0.70	1.05	7.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	37.47	3.93	0.91	0.00	7.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	51.16	2.69	0.37	1.10	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	75.11	6.55	1.60	0.44	14.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	53.54	3.04	0.61	1.22	6.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	48.53	1.81	0.30	0.60	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	47.27	2.26	0.23	1.13	6.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	68.89	3.59	0.90	0.00	17.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	57.74	3.19	0.24	1.06	3.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	44.18	4.48	1.28	0.64	6.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	62.50	3.61	0.00	1.20	13.82
Schwann Cells, donor1	11498-119F4	12.98	1.13	0.00	0.38	1.69
Schwann Cells, donor2	11578-120F3	20.41	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	9.42	1.31	0.00	0.00	1.31
Sebocyte, donor1	11220-116B5	26.84	3.83	2.74	0.00	5.48
Sebocyte, donor2	11301-117B5	8.73	1.38	0.46	0.00	3.68
Sebocyte, donor3	11378-118B1	18.76	0.62	1.24	0.00	3.50
Sertoli Cells, donor1	11255-116F4	33.13	4.97	0.00	1.66	3.31
Sertoli Cells, donor2	11333-117F1	53.66	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	41.79	3.17	0.35	0.18	6.42
Skeletal Muscle Cells, donor2	11358-117H8	5.06	2.17	0.72	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	32.61	1.67	0.84	0.00	5.85
Skeletal Muscle Cells, donor4	11451-119A2	27.81	2.51	0.31	0.00	5.03
Skeletal Muscle Cells, donor5	11455-119A6	26.76	1.34	0.59	0.15	5.05
Skeletal Muscle Cells, donor6	11459-119B1	35.55	1.85	0.46	0.77	4.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	26.71	3.91	0.00	0.25	6.30
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.53	3.42	0.43	0.00	7.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	31.05	2.38	0.30	0.20	5.95
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.52	3.03	0.67	0.42	4.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.12	1.45	0.00	0.00	5.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.15	1.51	0.28	0.28	4.40
Skin - palm, donor1	10286-104F7	34.92	2.69	0.00	0.00	13.43
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.50	1.44	0.43	0.00	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	31.90	3.27	3.27	0.82	5.73
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.04	1.95	0.52	0.00	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	15.15	3.34	0.83	0.00	2.36
Small Airway Epithelial Cells, donor2	11334-117F2	9.28	1.97	0.98	0.00	2.25
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	22.20	6.13	5.71	0.00	3.59
Small Airway Epithelial Cells, donor3	11406-118E2	19.19	2.62	1.05	0.15	5.25
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	52.77	2.78	0.00	1.23	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	27.12	3.11	0.44	0.00	2.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	24.69	1.76	1.18	0.00	7.64
Smooth Muscle Cells - Aortic, donor1	11283-116I5	18.78	2.21	0.00	0.22	9.06
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.48	1.18	0.39	0.00	2.36
Smooth Muscle Cells - Aortic, donor3	11432-118H1	31.68	1.55	0.00	0.00	6.18
Smooth Muscle Cells - Bladder, donor1	11519-119H7	16.01	3.00	0.00	0.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	17.57	2.40	0.27	0.27	4.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	21.28	1.33	0.00	0.22	6.21
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	16.26	1.41	0.26	0.51	1.41
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	6.84	0.00	0.33	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	14.47	2.36	0.59	0.00	3.25
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	8.68	1.99	0.00	0.00	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	25.54	1.46	0.00	0.00	3.58
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.61	1.52	1.22	0.00	12.48
Smooth Muscle Cells - Carotid, donor1	11285-116I7	18.94	1.77	1.77	0.00	5.05
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	0.00	6.12	0.00	48.97
Smooth Muscle Cells - Carotid, donor3	11434-118H3	16.69	0.48	0.00	0.00	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.30	2.21	0.44	0.15	1.92
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.76	1.08	0.65	0.00	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	9.97	1.15	0.10	0.00	1.15
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	18.41	2.78	0.00	0.15	2.78
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	15.09	0.00	0.00	0.00	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.63	1.49	0.00	0.00	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.90	1.71	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	15.23	2.28	0.00	0.00	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	41.77	3.82	0.40	0.30	34.62
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	49.38	2.28	0.68	0.46	10.24
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	27.78	2.42	0.60	0.00	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	19.87	1.59	0.00	0.00	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	10.39	2.53	0.13	0.00	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	17.53	1.88	0.13	0.38	1.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	24.86	2.03	0.51	0.25	3.04
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	33.47	4.07	0.75	0.00	8.14
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.75	0.75	0.75	0.00	9.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	12.92	18.09	3.88	0.00	25.84
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	22.79	1.86	0.00	0.00	7.91
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	29.79	3.53	0.00	0.00	9.59
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	27.58	3.13	0.63	0.63	14.42
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	9.14	0.00	0.00	0.00	3.24
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	11.41	1.67	0.25	0.00	2.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	9.34	3.27	0.00	0.00	7.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	16.12	1.73	0.00	0.14	4.32
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.57	2.04	0.00	0.00	4.59
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	11.09	0.94	0.00	0.19	2.63
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	16.21	2.52	0.00	0.00	2.38
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	15.08	1.84	0.00	0.00	1.01
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	16.67	0.48	0.00	0.00	4.29
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	17.37	0.49	0.24	0.24	4.16
Smooth Muscle Cells - Uterine, donor1	11258-116F7	29.61	3.54	2.21	0.44	3.09
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.95	2.93	1.46	0.00	4.97
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	24.30	2.72	0.39	0.19	8.16
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	21.69	1.59	0.26	0.26	6.35
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	12.27	0.74	0.74	0.00	9.30
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	15.09	3.59	0.36	0.72	7.55
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.13	2.27	0.28	0.00	8.80
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	18.91	2.76	0.79	0.79	7.48
Smooth muscle cells - airway, control, donor1	11966-126D4	26.66	2.03	0.76	0.51	8.38
Smooth muscle cells - airway, control, donor2	11967-126D5	18.37	2.00	0.00	0.40	11.98
Smooth muscle cells - airway, control, donor3	11968-126D6	16.72	2.09	0.42	0.00	6.69
Smooth muscle cells - airway, control, donor4	11969-126D7	17.42	3.21	0.46	0.00	8.25
Synoviocyte, donor1	11291-117A4	47.47	9.93	1.35	0.84	19.69
Synoviocyte, donor2	11368-117I9	44.76	3.18	1.01	0.00	15.92
Synoviocyte, donor3	11440-118H9	48.48	1.79	0.45	0.22	12.73
Trabecular Meshwork Cells, donor1	11532-120A2	13.58	1.79	0.00	0.00	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	11.11	1.16	0.00	0.23	3.47
Tracheal Epithelial Cells, donor1	11292-117A5	11.68	1.43	0.72	0.00	1.65
Tracheal Epithelial Cells, donor2	11369-118A1	8.50	1.55	0.77	0.00	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	5.73	1.15	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	44.29	4.18	0.49	0.00	10.95
Urethra, donor2	10319-105A4	8.99	1.80	1.80	0.00	12.59
Urothelial Cells, donor1	11520-119H8	15.14	0.80	0.27	0.00	1.33
Urothelial Cells, donor2	11600-120H7	13.22	0.80	1.20	0.00	2.00
Urothelial Cells, donor3	11681-122H7	19.48	1.38	0.23	0.00	2.06
Urothelial cells, donor0	11216-116B1	20.06	1.56	0.22	0.00	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	104.10	8.90	0.00	0.00	5.34
Whole blood (ribopure), donor090309, donation2	12180-129A2	98.64	14.30	0.00	0.00	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	56.13	5.48	0.68	0.00	8.90
Whole blood (ribopure), donor090325, donation1	12176-128I7	55.78	9.64	0.69	0.00	6.20
Whole blood (ribopure), donor090325, donation2	12177-128I8	62.75	5.23	0.00	0.00	5.23
Whole blood (ribopure), donor090612, donation1	12182-129A4	106.21	6.25	1.04	0.00	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	78.01	13.77	0.92	0.00	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	55.69	7.30	0.00	0.00	9.13
Wilms' tumor cell line:G-401	10809-111A8	47.86	4.93	1.36	0.00	9.99
Wilms' tumor cell line:HFWT	10597-108E3	23.76	2.64	0.00	0.00	26.40
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	52.23	5.31	0.84	0.00	8.66
achilles tendon, donor2	10292-104G4	6.20	2.07	0.00	0.00	8.27
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	26.01	3.06	0.00	0.00	14.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	19.04	9.29	0.70	0.00	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	131.41	10.80	0.36	0.12	10.21
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	32.38	5.71	0.00	0.00	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	50.60	7.03	0.56	0.00	7.87
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	40.60	9.94	0.21	0.21	4.86
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	21.23	10.07	1.09	0.00	16.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	35.69	6.61	0.88	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	44.92	10.21	0.82	0.41	8.98
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	60.57	15.92	1.55	0.39	10.10
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	19.87	4.42	1.10	0.00	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	66.31	19.50	3.90	0.00	19.50
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	34.16	10.92	0.70	0.00	5.34
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	27.70	5.95	0.26	0.00	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	34.78	3.80	0.29	0.00	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	52.05	6.51	1.86	0.00	12.08
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	39.48	8.23	0.41	0.00	4.11
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	14.12	1.84	0.61	0.00	4.60
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	34.99	5.97	0.43	0.00	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	31.24	4.25	0.61	0.00	3.94
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	40.20	7.46	0.48	0.00	3.61
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	28.73	6.24	1.34	0.00	3.12
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	18.68	1.33	0.00	0.00	14.68
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	5.57	1.86	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	30.51	4.90	0.38	0.00	3.39
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	19.63	8.29	0.00	0.00	4.36
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	1.87	0.00	0.00	7.50
adenocarcinoma cell line:IM95m	10796-110I4	28.26	5.42	0.00	0.00	5.89
adipose tissue, adult, pool1	10010-101C1	36.45	5.27	1.09	0.31	8.22
adipose, donor1	10184-103D4	30.49	5.28	0.59	0.00	2.35
adipose, donor2	10185-103D5	21.09	3.24	0.41	0.00	4.87
adipose, donor3	10186-103D6	15.79	3.81	0.27	0.27	11.16
adipose, donor4	10187-103D7	21.67	0.87	0.00	0.00	26.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	23.20	3.16	0.16	0.16	26.83
adrenal gland, adult, pool1	10081-102A9	10.91	3.64	0.00	0.00	14.55
adult T-cell leukemia cell line:ATN-1	10421-106C7	54.83	3.74	0.53	0.00	26.01
alveolar cell carcinoma cell line:SW 1573	10708-109H6	20.72	3.93	0.71	0.00	3.93
amniotic membrane cells, donor1	12235-129G3	79.06	6.49	0.70	0.70	6.72
amniotic membrane cells, donor2	12236-129G4	30.77	3.04	0.00	0.00	3.04
amniotic membrane cells, donor3	12237-129G5	70.12	2.95	0.29	0.29	13.55
amygdala - adult, donor10196	10167-103B5	7.11	1.19	0.00	0.00	4.74
amygdala, adult, donor10252	10151-102I7	14.80	1.22	1.62	0.20	8.11
amygdala, newborn, donor10223	10360-105E9	7.75	5.81	1.94	0.00	6.78
anaplastic carcinoma cell line:8305C	10428-106D5	30.81	1.78	0.51	0.13	7.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	5.96	0.00	0.00	0.00	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	31.07	3.34	0.67	0.00	2.67
aorta, adult, pool1	10052-101G7	34.72	4.31	0.59	0.00	18.04
appendix, adult	10189-103D9	35.32	12.03	0.00	0.00	20.18
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	21.67	3.10	0.34	0.00	2.75
artery, adult	10190-103E1	20.38	4.08	1.36	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	37.09	4.64	0.29	0.29	3.77
b cell line:RPMI1788	10427-106D4	63.50	8.18	0.45	0.00	14.13
basal cell carcinoma cell line:TE 354.T	10702-109G9	43.56	5.55	0.55	0.28	4.44
bile duct carcinoma cell line:HuCCT1	10432-106D9	17.37	1.98	0.20	0.30	1.19
bile duct carcinoma cell line:TFK-1	10496-107C1	7.36	0.67	0.00	0.00	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	17.90	2.24	0.00	0.00	1.68
bladder, adult, pool1	10011-101C2	58.45	5.98	0.54	0.00	11.19
blood, adult, pool1	10053-101G8	28.79	4.43	0.00	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	29.12	0.86	1.71	0.00	8.56
bone marrow, adult	10192-103E3	34.42	6.75	1.35	0.00	6.07
brain, adult, donor1	10084-102B3	4.10	3.08	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	17.26	2.45	1.22	0.00	6.57
brain, fetal, pool1	10085-102B4	16.03	0.00	0.00	0.00	16.03
breast carcinoma cell line:MCF7	10482-107A5	9.58	2.31	0.00	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	19.97	3.62	0.25	0.00	4.99
breast, adult, donor1	10080-102A8	17.05	6.31	0.63	0.00	8.84
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	12.20	3.05	2.79	0.13	2.03
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	44.84	6.80	0.31	0.93	18.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	37.76	4.60	1.15	0.23	23.94
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	19.85	3.15	0.00	0.00	7.99
carcinoid cell line:NCI-H1770	10703-109H1	29.15	0.47	0.00	0.00	4.23
carcinoid cell line:NCI-H727	10735-110B6	23.52	3.94	0.00	0.00	2.41
carcinoid cell line:SK-PN-DW	10719-109I8	12.36	0.63	0.32	0.00	3.80
carcinosarcoma cell line:JHUCS-1	10642-109A3	12.51	0.27	0.27	0.27	3.73
caudate nucleus - adult, donor10196	10177-103C6	16.12	0.00	1.15	1.15	6.91
caudate nucleus, adult, donor10252	10164-103B2	12.38	2.01	2.68	0.17	5.35
caudate nucleus, adult, donor10258	10379-105H1	7.64	0.00	0.76	0.00	4.58
caudate nucleus, newborn, donor10223	10354-105E3	10.25	2.20	1.46	0.00	5.49
cerebellum - adult, donor10196	10173-103C2	23.31	2.91	0.00	0.00	23.31
cerebellum, adult, donor10252	10166-103B4	33.09	1.28	3.42	0.21	14.31
cerebellum, adult, pool1	10083-102B2	9.66	0.34	1.03	0.00	6.21
cerebellum, newborn, donor10223	10357-105E6	8.30	0.83	0.00	0.00	9.13
cerebral meninges, adult	10188-103D8	11.60	5.80	1.01	0.00	4.54
cerebrospinal fluid, donor2	10294-104G6	7.31	1.46	0.00	0.00	7.31
cervical cancer cell line:D98-AH2	10552-107I3	20.99	1.73	0.00	0.14	1.44
cervical cancer cell line:ME-180	10553-107I4	70.60	7.13	3.48	0.17	7.29
cervix, adult, pool1	10013-101C4	39.06	8.08	1.78	0.00	12.18
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	25.92	2.37	0.42	0.28	2.09
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	1.31	0.00	0.00	10.45
choriocarcinoma cell line:BeWo	10423-106C9	33.06	3.73	0.12	0.12	2.49
choriocarcinoma cell line:SCH	10785-110H2	39.43	1.85	0.00	0.25	8.50
choriocarcinoma cell line:T3M-3	10618-108G6	19.92	2.37	0.24	0.00	0.71
chorionic membrane cells, donor1	12238-129G6	54.70	6.55	0.00	0.00	6.27
chorionic membrane cells, donor2	12239-129G7	12.43	1.29	0.00	0.30	2.09
chorionic membrane cells, donor3	12240-129G8	51.10	3.85	0.00	0.00	10.99
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	8.08	4.04	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	15.94	5.96	0.19	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	8.03	3.17	0.21	0.00	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.88	3.08	0.26	0.00	3.34
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	28.06	3.87	0.24	0.00	2.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	27.28	2.85	0.00	0.00	3.05
chronic myelogenous leukemia cell line:K562	10454-106G4	22.67	2.65	0.00	0.29	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	10.16	2.35	0.26	0.00	1.82
clear cell carcinoma cell line:JHOC-5	10638-108I8	21.72	1.14	0.00	0.00	3.20
clear cell carcinoma cell line:TEN	10636-108I6	49.97	6.42	0.00	0.69	5.73
colon carcinoma cell line:CACO-2	10513-107D9	29.84	4.76	0.00	0.18	3.48
colon carcinoma cell line:COLO-320	10420-106C6	86.66	7.22	0.00	0.38	14.06
colon, adult, donor1	10082-102B1	13.09	2.38	1.19	0.00	10.71
colon, adult, pool1	10014-101C5	24.91	7.17	0.00	0.00	7.05
colon, fetal, donor1	10070-101I7	18.54	3.09	0.00	0.00	6.80
common myeloid progenitor CMP, donor1	12130-128D6	155.84	41.25	0.00	0.00	22.92
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	138.10	39.94	2.55	0.00	56.09
cord blood derived cell line:COBL-a 24h infection	10453-106G3	46.79	24.60	0.60	0.00	17.96
cord blood derived cell line:COBL-a untreated	10449-106F8	44.28	27.64	0.56	0.00	16.50
corpus callosum, adult, pool1	10042-101F6	38.70	3.10	0.44	0.00	10.50
cruciate ligament, donor2	10295-104G7	19.45	2.43	0.00	0.00	15.40
diaphragm, fetal, donor1	10069-101I6	19.26	3.21	0.00	0.00	12.04
diencephalon, adult	10193-103E4	14.16	0.00	0.72	0.24	5.04
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	39.03	5.97	0.00	0.00	12.86
ductal cell carcinoma cell line:KLM-1	10438-106E6	23.85	6.15	0.51	0.26	7.18
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	17.57	1.69	0.24	0.00	2.89
ductus deferens, adult	10196-103E7	16.45	3.99	1.00	0.00	12.46
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	1.44	2.88	0.00	10.08
duodenum, fetal, donor1, tech_rep2	10071-101I8	34.58	4.41	0.00	0.00	8.83
dura mater, adult, donor1	10041-101F5	50.21	11.15	0.50	0.00	8.01
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	32.42	6.66	0.44	0.00	3.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	22.64	3.58	0.43	0.00	3.87
embryonic pancreas cell line:1B2C6	10604-108F1	51.80	1.85	1.23	0.62	24.05
embryonic pancreas cell line:1C3D3	10605-108F2	33.90	1.82	0.00	0.61	9.69
embryonic pancreas cell line:1C3IKEI	10606-108F3	55.88	2.47	0.31	0.00	24.08
embryonic pancreas cell line:2C6	10603-108E9	49.91	2.63	0.00	0.00	14.45
endometrial carcinoma cell line:OMC-2	10497-107C2	12.74	1.01	0.00	0.00	3.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	13.05	2.17	0.54	0.00	6.34
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	33.61	1.93	0.00	0.16	9.49
epidermoid carcinoma cell line:A431	10426-106D3	48.35	6.34	1.56	0.00	6.34
epidermoid carcinoma cell line:Ca Ski	10431-106D8	47.62	4.07	0.77	1.10	4.18
epididymis, adult	10197-103E8	24.07	2.51	1.47	0.00	11.51
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	24.31	1.95	0.53	0.00	6.21
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	13.37	0.79	0.79	0.00	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	9.30	1.31	0.26	0.00	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	13.78	1.48	0.20	0.20	1.67
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	7.73	1.57	0.00	0.11	0.78
esophagus, adult, pool1	10015-101C6	63.71	6.80	0.96	0.11	11.25
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	15.15	2.88	0.50	0.13	14.28
eye - muscle inferior rectus, donor1	10272-104E2	12.07	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	6.31	2.10	0.00	0.00	6.31
eye - muscle medial, donor2	10299-104H2	4.46	2.98	0.00	0.00	5.95
eye - muscle superior, donor2	10297-104G9	8.03	2.29	0.00	0.00	6.88
eye - vitreous humor, donor1	10268-104D7	21.86	2.91	0.00	0.00	13.12
eye, fetal, donor1	10054-101G9	28.98	2.80	0.00	0.00	13.47
fibrosarcoma cell line:HT-1080	10758-110E2	12.82	1.54	0.00	0.13	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	18.28	1.42	0.24	0.00	3.56
frontal lobe, adult, pool1	10040-101F4	16.61	2.81	3.66	0.19	4.79
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	29.12	2.40	0.00	0.00	3.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	113.93	10.15	0.09	1.10	16.09
gall bladder, adult	10198-103E9	24.14	3.38	0.97	0.00	10.38
gamma delta positive T cells, donor1	11937-126A2	23.62	10.74	0.00	0.00	2.68
gamma delta positive T cells, donor2	11938-126A3	41.83	18.67	0.37	0.37	4.48
gastric adenocarcinoma cell line:MKN1	10614-108G2	29.99	2.32	0.21	0.42	3.17
gastric adenocarcinoma cell line:MKN45	10612-108F9	20.89	3.29	0.00	0.00	5.80
gastric cancer cell line:AZ521	10549-107H9	17.54	2.95	1.48	0.00	2.79
gastric cancer cell line:GSS	10560-108A2	26.54	0.92	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	34.50	4.34	0.23	0.00	5.25
giant cell carcinoma cell line:LU65	10487-107B1	19.96	1.15	0.11	0.80	3.67
giant cell carcinoma cell line:Lu99B	10433-106E1	60.88	5.60	0.70	0.70	6.58
glassy cell carcinoma cell line:HOKUG	10688-109F4	13.47	2.00	0.25	0.50	2.74
glioblastoma cell line:A172, tech_rep1	10444-106F3	14.78	2.74	0.11	0.21	1.58
glioblastoma cell line:A172, tech_rep2	10444-106F3	13.76	1.26	0.00	0.14	2.39
glioblastoma cell line:T98G	10485-107A8	17.33	3.09	0.22	0.33	4.53
glioma cell line:GI-1	10413-106B8	18.74	2.05	0.29	0.29	7.61
globus pallidus - adult, donor10196	10175-103C4	20.41	2.92	0.00	0.00	16.76
globus pallidus, adult, donor10252	10161-103A8	29.29	2.20	1.71	0.00	22.21
globus pallidus, adult, donor10258	10367-105F7	13.69	1.37	0.00	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	11.72	2.13	0.53	0.53	3.73
granulocyte macrophage progenitor, donor1	12131-128D7	195.77	61.18	2.45	0.00	14.68
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	20.91	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	33.28	2.24	0.00	0.64	9.28
hIPS +CCl2, biol_rep1	14383-156B9	16.99	0.46	0.46	0.00	1.84
hIPS +CCl2, biol_rep2	14384-156C1	10.52	0.91	0.00	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	14.17	1.93	0.64	0.00	1.93
hIPS, biol_rep1	14380-156B6	24.43	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	6.86	2.06	0.69	0.00	2.06
hIPS, biol_rep3	14382-156B8	3.31	0.00	0.00	0.00	2.21
hairy cell leukemia cell line:Mo	10712-109I1	45.11	6.90	0.29	0.29	30.75
heart - mitral valve, adult	10205-103F7	29.30	4.19	0.60	0.00	11.06
heart - pulmonic valve, adult	10206-103F8	27.45	3.92	1.05	0.00	10.20
heart - tricuspid valve, adult	10207-103F9	30.81	2.50	0.00	0.00	11.66
heart, adult, diseased post-infarction, donor1	10050-101G5	27.14	2.65	0.41	0.20	4.69
heart, adult, diseased, donor1	10051-101G6	24.27	3.83	0.00	0.00	4.26
heart, adult, pool1	10016-101C7	28.52	5.52	0.00	0.00	2.53
heart, fetal, pool1	10046-101G1	63.05	12.01	0.21	0.41	2.98
hepatic mesenchymal tumor cell line:LI90	10778-110G4	22.52	2.47	0.00	0.00	5.24
hepatoblastoma cell line:HuH-6	10633-108I3	7.14	0.00	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	46.63	4.97	0.55	0.44	3.65
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	44.30	3.76	0.12	0.36	4.37
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	49.42	5.25	0.10	0.61	4.75
hepatoma cell line:Li-7	10484-107A7	12.90	1.56	0.11	0.33	2.45
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	21.51	3.52	0.20	0.00	7.44
hippocampus - adult, donor10196	10169-103B7	11.36	1.89	0.00	0.00	5.68
hippocampus, adult, donor10252	10153-102I9	19.19	0.82	1.02	0.00	8.78
hippocampus, adult, donor10258	10374-105G5	10.46	2.99	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	5.29	1.76	0.70	0.70	4.93
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	8.54	2.44	0.61	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	7.07	0.79	0.20	0.79	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	10.66	0.51	0.25	0.00	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	27.07	2.26	0.00	0.00	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	29.18	5.42	0.00	0.00	4.39
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	31.89	6.83	0.00	0.00	3.42
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	26.86	3.80	0.29	0.29	8.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	27.14	3.02	0.00	0.22	9.05
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	18.35	2.92	0.83	0.42	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	12.31	2.37	0.00	0.00	3.08
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	23.14	4.66	1.13	0.16	3.21
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	5.39	0.00	0.00	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	6.42	0.94	0.16	0.16	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	2.95	0.00	0.00	0.00	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1.75	1.75	0.00	0.87	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	36.85	6.87	0.19	0.57	2.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	30.09	1.74	0.44	0.44	4.80
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	31.98	8.50	0.00	0.50	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	41.63	5.09	0.19	0.00	4.14
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	44.11	3.64	0.45	0.00	4.09
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	26.94	2.82	0.00	0.31	5.95
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	12.74	2.45	0.33	0.33	2.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	12.19	2.32	0.00	0.29	2.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.96	2.09	0.30	0.60	2.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	8.31	1.29	0.18	0.18	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	9.41	0.29	0.00	0.29	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	9.39	2.04	0.41	0.00	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	30.28	3.52	0.00	0.00	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	24.07	4.43	0.00	0.00	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	26.33	5.75	0.00	0.61	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	16.03	5.69	0.52	0.00	4.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	19.26	1.99	0.66	0.00	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	14.62	1.54	0.26	0.00	3.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	15.34	2.81	0.26	0.77	3.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.87	1.51	0.00	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	14.11	1.01	0.34	1.68	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	11.11	1.21	0.24	0.24	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	11.59	1.34	0.45	0.00	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	10.24	1.46	0.49	0.00	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	40.04	4.89	0.31	0.92	3.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	35.79	3.25	3.25	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	36.40	4.30	0.66	0.00	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	24.63	4.93	0.00	0.00	6.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	27.14	2.53	0.36	0.36	5.43
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	26.33	2.85	0.00	0.00	6.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	23.87	2.39	0.00	0.00	4.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	28.44	4.74	0.27	0.27	5.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	20.47	2.42	0.27	0.54	6.73
immature langerhans cells, donor1	11904-125F5	83.30	29.54	0.97	0.73	8.96
immature langerhans cells, donor2	11905-125F6	91.89	18.22	2.38	0.00	24.56
insula, adult, pool1	10039-101F3	18.74	3.31	2.56	0.00	4.16
keratoacanthoma cell line:HKA-1	10791-110H8	13.01	3.25	3.25	0.00	5.53
kidney, adult, pool1	10017-101C8	16.02	3.50	0.50	0.20	4.21
kidney, fetal, pool1	10045-101F9	46.19	5.52	0.21	0.07	5.09
large cell lung carcinoma cell line:IA-LM	10509-107D5	46.72	2.56	0.28	0.14	6.53
large cell lung carcinoma cell line:NCI-H460	10839-111E2	11.75	2.63	0.14	0.00	1.52
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	47.71	3.30	0.00	0.92	4.77
left atrium, adult, donor1	10079-102A7	8.72	3.27	0.54	0.00	8.17
left ventricle, adult, donor1	10078-102A6	19.21	3.54	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	25.17	3.28	1.37	0.00	13.95
leiomyoma cell line:10964C	10569-108B2	17.24	3.95	0.36	0.00	10.06
leiomyoma cell line:15242A	10570-108B3	21.20	1.09	1.09	1.09	4.35
leiomyoma cell line:15425	10571-108B4	22.82	2.43	1.46	0.24	14.08
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	6.35	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	7.32	1.05	0.00	2.09	5.23
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	15.70	2.60	0.12	0.00	1.30
liposarcoma cell line:KMLS-1	10782-110G8	49.36	2.81	1.72	0.00	15.31
liposarcoma cell line:SW 872	10726-110A6	10.72	1.71	0.00	0.24	2.92
liver, adult, pool1	10018-101C9	17.99	2.92	0.16	0.00	5.51
liver, fetal, pool1	10086-102B5	22.58	0.00	0.00	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	17.06	0.73	0.73	0.00	15.60
locus coeruleus, adult, donor10252	10165-103B3	19.38	1.11	1.11	0.00	8.49
locus coeruleus, adult, donor10258	10375-105G6	5.92	0.28	0.00	0.00	4.80
locus coeruleus, newborn, donor10223	10362-105F2	4.21	2.52	1.26	0.84	5.89
lung adenocarcinoma cell line:A549	10499-107C4	18.41	3.60	0.00	0.00	3.04
lung adenocarcinoma cell line:PC-14	10408-106B3	8.96	1.38	0.00	0.00	10.34
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	110.07	5.54	0.26	0.00	46.93
lung, adult, pool1	10019-101D1	39.93	6.14	0.24	0.00	8.03
lung, fetal, donor1	10068-101I5	111.59	11.42	3.14	0.00	5.42
lung, right lower lobe, adult, donor1	10075-102A3	21.08	4.58	1.37	0.00	13.75
lymph node, adult, donor1	10077-102A5	20.83	4.26	0.00	0.00	9.47
lymphangiectasia cell line:DS-1	10727-110A7	24.99	1.97	0.00	0.00	14.90
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	67.31	10.87	0.00	0.30	46.64
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	38.23	1.70	0.00	0.00	4.25
mature adipocyte, donor1	12231-129F8	33.74	4.88	0.00	0.44	12.43
mature adipocyte, donor2	12232-129F9	36.11	5.19	0.21	0.00	11.00
mature adipocyte, donor3	12233-129G1	43.86	4.27	0.47	0.00	11.85
mature adipocyte, donor4	12234-129G2	45.01	7.63	0.00	0.26	11.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	34.31	6.91	0.00	0.00	3.34
medial frontal gyrus - adult, donor10196	10170-103B8	9.02	1.13	0.00	0.00	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	16.37	2.94	2.76	0.18	7.72
medial frontal gyrus, adult, donor10258	10368-105F8	6.67	1.59	1.27	0.00	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	8.10	3.84	2.99	0.00	7.25
medial temporal gyrus - adult, donor10196	10183-103D3	9.28	1.86	1.18	0.00	12.99
medial temporal gyrus, adult, donor10252	10156-103A3	17.83	1.27	2.12	0.00	9.55
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	3.85	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	12.20	5.03	2.15	0.00	13.28
medulla oblongata - adult, donor10196	10174-103C3	13.63	0.65	0.00	0.00	6.49
medulla oblongata, adult, donor10252	10155-103A2	20.12	1.08	0.93	0.00	12.38
medulla oblongata, adult, pool1	10038-101F2	27.43	2.69	1.14	0.00	8.08
medulla oblongata, newborn, donor10223	10361-105F1	9.03	1.04	0.00	0.00	6.25
medulloblastoma cell line:D283 Med	10838-111E1	29.45	2.66	0.00	0.00	8.64
medulloblastoma cell line:ONS-76	10759-110E3	14.92	1.96	0.98	0.00	5.99
melanoma cell line:COLO 679	10514-107E1	25.30	4.89	0.57	0.57	1.44
melanoma cell line:G-361	10465-106H6	25.25	4.89	0.54	1.09	5.70
meningioma cell line:HKBMM	10691-109F7	19.54	3.08	0.00	0.00	4.34
merkel cell carcinoma cell line:MKL-1	10843-111E6	19.39	2.64	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	48.47	6.74	0.00	0.00	5.18
mesenchymal precursor cell - adipose, donor1	11747-123G1	25.47	2.92	0.92	0.00	6.14
mesenchymal precursor cell - adipose, donor2	11748-123G2	24.18	2.00	0.73	0.00	5.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	24.85	3.31	1.24	0.00	4.97
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	27.25	2.11	0.28	0.14	10.96
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	25.80	2.31	1.16	0.00	13.09
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	38.17	4.86	0.69	0.00	19.43
mesenchymal precursor cell - cardiac, donor1	11752-123G6	21.28	2.92	0.17	0.17	2.75
mesenchymal precursor cell - cardiac, donor2	11753-123G7	44.63	3.45	0.46	0.12	12.42
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.46	2.39	0.53	0.13	2.52
mesenchymal precursor cell - cardiac, donor4	11755-123G9	18.23	1.62	0.27	0.41	2.43
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	11.81	1.71	0.28	0.14	1.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	15.48	2.31	0.00	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	12.45	2.21	0.28	0.14	1.94
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	9.77	2.09	0.35	0.35	4.54
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	17.15	1.84	0.00	0.00	1.63
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.38	1.08	0.00	0.00	2.88
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.66	1.86	0.00	0.10	1.34
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	12.77	2.28	0.00	0.23	2.05
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	17.62	1.68	0.00	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	17.04	2.84	0.15	0.00	2.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	8.05	1.93	0.18	0.09	1.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	58.91	3.68	0.00	0.37	15.09
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	21.75	1.43	0.00	0.29	2.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	63.57	2.53	0.42	0.84	5.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	29.23	3.20	0.46	0.46	6.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	27.88	1.79	0.51	0.77	7.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	34.03	3.14	0.00	0.00	4.97
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	24.65	2.16	0.00	0.31	9.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	30.36	3.29	0.47	0.24	9.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	29.45	2.71	0.00	0.34	7.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	34.58	1.96	0.39	0.00	11.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	23.17	1.85	0.46	0.00	9.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	96.61
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	28.26	2.60	1.44	0.29	11.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.09	1.12	0.22	0.00	10.04
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	22.59	1.68	0.96	0.24	8.17
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	25.67	2.93	0.73	0.00	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	18.46	1.34	0.67	0.00	6.04
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	19.24	3.28	0.41	0.41	9.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.89	1.72	0.43	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	8.20	0.00	0.00	8.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.32	1.30	0.32	0.00	4.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	1.45	0.00	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	11.73	1.60	0.00	0.00	7.46
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.09	0.82	0.82	0.00	5.72
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.00	0.78	1.17	0.00	4.28
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	0.00	0.00	0.00	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	7.95	0.00	0.00	0.00	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	4.74	0.00	0.00	0.00	5.34
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	0.00	0.00	0.00	6.09
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.03	0.63	0.63	0.00	5.70
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.42	1.38	0.34	0.00	4.83
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	0.00	0.00	0.00	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.15	2.44	0.00	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	2.38	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.15	0.59	0.00	0.00	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.60	1.25	0.00	0.00	3.12
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	14.19	0.00	0.00	0.00	5.91
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	6.88	0.69	0.69	0.00	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.35	0.99	0.99	0.00	2.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	16.82	1.12	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	4.45	0.00	0.00	4.45
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	7.66	1.61	0.00	0.00	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	0.00	0.00	0.00	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	9.71	1.21	0.00	0.00	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	7.41	3.29	0.00	0.00	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	13.49	1.79	0.40	0.00	5.16
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	10.71	0.65	0.65	0.32	3.24
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	13.24	1.02	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	18.57	3.09	0.00	0.00	6.19
mesothelioma cell line:ACC-MESO-1	10493-107B7	30.95	1.18	0.94	0.00	14.88
mesothelioma cell line:ACC-MESO-4	10494-107B8	8.80	2.32	0.00	0.23	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	0.00	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	20.34	2.47	0.10	0.31	1.64
mesothelioma cell line:Mero-25	10850-111F4	9.76	1.13	0.00	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	33.25	5.13	0.24	0.24	2.20
mesothelioma cell line:Mero-48a	10852-111F6	20.59	1.11	0.00	0.22	2.21
mesothelioma cell line:Mero-82	10853-111F7	25.23	4.47	0.79	0.79	0.53
mesothelioma cell line:Mero-83	10854-111F8	9.36	0.68	0.00	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	3.29	0.00	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	12.42	1.45	0.41	0.41	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	61.95	5.96	0.83	1.33	4.31
mesothelioma cell line:NCI-H226	10846-111E9	11.04	1.63	0.00	0.18	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	18.96	3.07	0.17	0.00	2.73
mesothelioma cell line:NCI-H28	10845-111E8	14.76	1.02	0.00	0.25	0.51
mesothelioma cell line:No36	10857-111G2	12.40	0.98	0.00	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	16.80	1.90	0.00	0.27	1.90
migratory langerhans cells, donor1	11901-125F2	143.56	7.10	0.77	0.19	19.19
migratory langerhans cells, donor2	11902-125F3	85.36	8.06	0.61	0.00	11.60
migratory langerhans cells, donor3	11903-125F4	94.77	7.18	0.36	0.00	16.69
mixed mullerian tumor cell line:HTMMT	10689-109F5	18.94	1.63	0.33	0.33	3.26
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	22.47	2.54	0.00	0.64	3.60
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	24.65	0.92	0.00	0.00	4.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	36.16	10.47	2.09	0.19	27.78
myelodysplastic syndrome cell line:SKM-1	10772-110F7	39.73	6.10	0.37	0.00	2.59
myeloma cell line:PCM6	10474-106I6	15.62	1.98	0.00	0.00	1.98
myxofibrosarcoma cell line:MFH-ino	10600-108E6	7.61	0.51	0.00	0.51	5.07
myxofibrosarcoma cell line:NMFH-1	10684-109E9	57.47	2.55	0.39	0.39	15.89
nasal epithelial cells, donor1, tech_rep1	12226-129F3	14.04	0.89	0.11	0.00	2.90
nasal epithelial cells, donor1, tech_rep2	12226-129F3	15.44	0.59	0.22	0.07	3.38
nasal epithelial cells, donor2	12227-129F4	29.81	2.21	1.10	0.00	2.76
neuroblastoma cell line:CHP-134	10508-107D4	12.65	4.83	0.23	0.00	2.07
neuroblastoma cell line:NB-1	10539-107G8	57.81	9.54	2.62	0.00	11.97
neuroblastoma cell line:NBsusSR	10607-108F4	10.97	1.69	0.21	0.00	1.05
neuroblastoma cell line:NH-12	10555-107I6	41.74	5.03	0.00	0.19	5.22
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	8.07	3.08	0.24	0.24	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	9.19	0.32	0.00	0.00	2.06
neuroectodermal tumor cell line:TASK1	10774-110F9	16.50	1.21	0.00	0.40	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.81	0.64	0.00	0.00	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	23.69	3.19	0.80	0.53	6.39
neutrophil PMN, donor1	12133-128D9	133.87	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	92.96	66.40	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	142.06	9.47	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	45.32	33.15	0.00	0.00	5.75
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.01	1.60	1.60	0.00	9.61
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	18.60	3.53	0.96	0.00	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	15.24	2.10	0.00	0.00	2.63
nucleus accumbens, adult, pool1	10037-101F1	18.37	2.72	2.81	0.19	4.41
occipital cortex - adult, donor10196	10172-103C1	20.60	4.12	0.00	0.00	12.36
occipital cortex, adult, donor10252	10163-103B1	21.74	3.22	2.68	0.00	13.69
occipital cortex, newborn, donor10223	10355-105E4	12.37	4.73	2.55	0.00	13.47
occipital lobe, adult, donor1	10076-102A4	9.71	3.41	0.79	0.26	4.46
occipital lobe, fetal, donor1	10073-102A1	14.59	2.15	0.00	0.00	3.86
occipital pole, adult, pool1	10036-101E9	16.16	1.81	1.89	0.16	5.12
olfactory region, adult	10195-103E6	14.71	1.15	1.53	0.00	5.35
optic nerve, donor1	10277-104E7	16.01	0.00	0.00	0.00	20.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	19.48	3.87	1.94	0.11	5.70
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	33.11	1.92	0.00	0.14	5.63
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	22.52	3.56	1.69	0.17	4.74
oral squamous cell carcinoma cell line:SAS	10544-107H4	30.73	6.12	1.85	0.12	1.85
osteoclastoma cell line:Hs 706.T	10704-109H2	32.04	2.35	0.29	0.00	3.23
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	14.95	3.74	0.93	0.00	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	14.84	1.48	0.64	0.00	4.88
ovary, adult, pool1	10020-101D2	33.11	4.37	0.79	0.00	9.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.76	2.57	0.18	0.37	8.62
pancreas, adult, donor1	10049-101G4	15.05	1.88	0.94	0.00	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	15.37	2.80	0.00	0.28	6.99
papillary adenocarcinoma cell line:8505C	10437-106E5	26.92	2.56	0.51	0.17	6.30
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	19.04	4.31	0.00	0.17	2.98
paracentral gyrus, adult, pool1	10035-101E8	16.47	2.93	1.74	0.18	4.48
parietal cortex, adult, donor10258	10373-105G4	13.21	1.47	1.47	0.00	4.40
parietal lobe - adult, donor10196	10171-103B9	15.05	0.94	0.00	0.00	4.70
parietal lobe, adult, donor10252	10157-103A4	18.53	2.00	2.28	0.00	9.12
parietal lobe, adult, pool1	10034-101E7	17.18	1.59	1.67	0.09	5.73
parietal lobe, fetal, donor1	10072-101I9	16.49	2.91	1.94	0.97	9.70
parietal lobe, newborn, donor10223	10356-105E5	14.95	5.23	2.62	0.37	13.09
parotid gland, adult	10199-103F1	27.13	3.70	1.23	0.00	2.47
penis, adult	10200-103F2	22.02	9.13	2.15	0.00	10.74
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	15.99	0.19	0.00	0.00	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	10.20	3.06	0.58	0.00	3.21
pineal gland - adult, donor10196	10179-103C8	14.19	0.65	1.94	0.00	54.18
pineal gland, adult, donor10252	10160-103A7	17.17	1.18	1.78	0.00	99.49
pineal gland, adult, donor10258	10377-105G8	7.52	0.63	1.25	0.00	25.71
pituitary gland - adult, donor10196	10180-103C9	9.11	1.01	0.00	0.00	6.07
pituitary gland, adult, donor10252	10162-103A9	41.17	1.04	2.08	0.00	22.93
pituitary gland, adult, donor10258	10378-105G9	6.81	2.55	0.00	0.00	10.21
placenta, adult, pool1	10021-101D3	46.66	4.41	0.65	0.11	10.97
plasma cell leukemia cell line:ARH-77	10840-111E3	41.18	6.09	0.00	0.13	20.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	34.86	3.11	0.78	0.16	10.58
pons, adult, pool1	10033-101E6	19.37	1.72	0.17	0.00	4.73
postcentral gyrus, adult, pool1	10032-101E5	14.30	2.01	1.66	0.09	3.66
promyelocytes/myelocytes PMC, donor1	12132-128D8	98.30	35.55	0.00	0.00	8.37
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	40.35	2.77	0.15	0.15	16.46
prostate cancer cell line:PC-3	10439-106E7	41.20	2.72	0.18	0.36	46.46
prostate, adult, pool1	10022-101D4	24.49	4.35	0.82	0.00	8.07
putamen, adult, donor10196	10176-103C5	15.11	1.65	1.18	0.71	5.43
putamen, adult, donor10252	10152-102I8	9.80	0.00	1.96	0.00	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	16.39	0.00	2.19	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	8.46	1.93	1.45	0.00	1.93
putamen, newborn, donor10223	10365-105F5	10.50	1.50	3.00	0.00	5.25
rectal cancer cell line:TT1TKB	10469-106I1	15.42	3.20	0.00	0.00	2.62
rectum, fetal, donor1	10067-101I4	22.26	5.56	0.00	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	40.70	6.36	0.64	0.21	10.18
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	63.37	1.24	0.00	0.00	12.43
retina, adult, pool1	10030-101E3	32.30	9.94	1.09	0.10	19.48
retinoblastoma cell line:Y79	10475-106I7	25.20	5.46	0.26	0.00	4.16
rhabdomyosarcoma cell line:KYM-1	10787-110H4	17.34	1.72	0.74	0.00	4.55
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	73.67	6.47	2.25	0.28	18.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	25.01	3.79	0.76	0.00	15.91
salivary acinar cells, donor1	11771-123I7	13.43	1.29	2.75	0.00	8.42
salivary acinar cells, donor2	11772-123I8	18.31	2.48	2.89	0.00	4.82
salivary acinar cells, donor3	11773-123I9	11.92	5.96	2.65	0.00	17.88
salivary gland, adult, pool1	10093-102C3	67.49	6.29	1.72	0.00	3.43
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	29.51	3.29	0.59	0.42	14.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	23.86	3.76	0.59	0.35	17.40
seminal vesicle, adult	10201-103F3	19.05	7.41	0.53	0.00	9.52
serous adenocarcinoma cell line:JHOS-2	10639-108I9	50.29	5.59	0.49	0.00	15.06
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	68.95	4.03	0.75	0.00	5.28
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	37.13	4.01	1.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	48.49	2.96	0.00	0.27	1.61
signet ring carcinoma cell line:Kato III	10436-106E4	28.85	3.32	0.00	0.22	2.21
signet ring carcinoma cell line:NUGC-4	10483-107A6	29.93	4.13	0.00	0.00	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	4.26	4.26	0.00	0.00	2.84
skeletal muscle, adult, pool1	10023-101D5	28.43	5.40	0.48	0.24	3.72
skeletal muscle, fetal, donor1	10066-101I3	31.16	3.02	0.00	0.00	4.02
skin, adult, donor1	10074-102A2	61.07	6.79	6.79	0.00	27.14
skin, fetal, donor1	10065-101I2	25.88	11.36	1.89	0.00	13.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	10.67	2.67	0.00	0.00	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	31.84	1.26	0.63	0.00	14.50
small cell lung carcinoma cell line:DMS 144	10841-111E4	21.59	2.70	0.00	0.00	5.01
small cell lung carcinoma cell line:LK-2	10541-107H1	17.31	3.46	0.00	0.00	1.81
small cell lung carcinoma cell line:NCI-H82	10842-111E5	49.06	1.93	0.16	0.00	8.85
small cell lung carcinoma cell line:WA-hT	10562-108A4	59.49	5.01	0.00	0.22	13.95
small intestine, adult, pool1	10024-101D6	24.96	7.52	0.00	0.00	5.85
small intestine, fetal, donor1	10064-101I1	20.88	3.44	0.00	0.00	3.93
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	25.13	5.64	0.00	0.00	3.59
smooth muscle, adult, pool1	10048-101G3	21.19	5.43	0.52	0.26	5.69
somatostatinoma cell line:QGP-1	10781-110G7	5.90	1.34	0.00	0.00	4.82
spinal cord - adult, donor10196	10181-103D1	17.43	1.15	0.69	0.00	23.63
spinal cord, adult, donor10252	10159-103A6	23.66	1.97	0.39	0.00	15.77
spinal cord, adult, donor10258	10369-105F9	15.91	4.15	1.38	0.00	7.61
spinal cord, fetal, donor1	10056-101H2	10.37	2.44	1.22	0.00	2.44
spinal cord, newborn, donor10223	10359-105E8	13.32	0.92	0.92	0.00	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	46.75	6.12	0.90	0.15	9.56
spleen, adult, pool1	10025-101D7	63.88	9.91	0.99	0.00	18.06
spleen, fetal, pool1	10044-101F8	78.34	9.53	1.19	0.08	11.12
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	41.09	4.35	0.52	0.10	34.06
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	20.51	2.47	0.00	0.00	3.42
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	46.13	4.89	0.70	0.35	9.09
squamous cell carcinoma cell line:T3M-5	10616-108G4	23.06	1.56	0.39	0.00	3.91
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	34.44	2.59	0.11	0.23	7.99
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	44.90	4.24	0.85	0.42	2.97
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	34.69	2.96	0.85	0.42	16.08
stomach, fetal, donor1	10062-101H8	6.41	4.27	0.00	0.00	7.48
submaxillary gland, adult	10202-103F4	33.04	5.13	0.57	0.00	10.82
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	28.87	1.04	0.21	0.00	11.84
substantia nigra, adult, donor10258	10371-105G2	12.93	1.03	0.52	0.00	1.55
substantia nigra, newborn, donor10223	10358-105E7	7.07	0.00	0.00	0.00	5.65
synovial sarcoma cell line:HS-SY-II	10441-106E9	36.91	4.81	0.46	0.23	3.90
temporal lobe, adult, pool1	10031-101E4	13.05	2.54	1.44	0.00	3.73
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	18.52	0.71	2.14	0.00	12.82
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	16.70	2.20	0.88	0.00	3.96
tenocyte, donor1	11763-123H8	57.25	1.75	1.05	1.05	13.61
tenocyte, donor2	11765-123I1	52.65	1.91	0.00	0.38	12.21
tenocyte, donor3	11768-123I4	53.75	3.34	0.37	0.74	11.86
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	14.45	1.36	0.34	0.00	1.70
teratocarcinoma cell line:NCR-G1	10798-110I6	26.98	2.31	0.15	0.46	2.31
teratocarcinoma cell line:PA-1	10807-111A6	9.76	1.70	0.00	0.00	1.39
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	12.31	1.14	0.00	0.00	2.67
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	24.20	1.89	0.38	0.00	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	19.09	1.96	0.11	0.00	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	12.70	1.95	0.00	0.00	1.30
testis, adult, pool1	10026-101D8	27.17	7.84	0.43	0.11	13.53
testis, adult, pool2	10096-102C6	29.32	5.41	0.45	0.00	11.73
thalamus - adult, donor10196	10168-103B6	23.18	0.00	0.00	0.00	12.14
thalamus, adult, donor10252	10154-103A1	33.91	2.81	2.19	0.00	14.38
thalamus, adult, donor10258, tech_rep1	10370-105G1	24.63	0.00	1.54	0.00	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	4.94	1.15	0.82	0.00	4.28
thalamus, newborn, donor10223	10366-105F6	5.75	1.73	0.00	0.00	4.03
throat, adult	10209-103G2	46.44	7.24	1.25	0.00	7.49
throat, fetal, donor1	10061-101H7	23.77	3.96	0.91	0.91	9.14
thymic carcinoma cell line:Ty-82	10803-111A2	16.30	1.99	0.20	0.00	0.99
thymus, adult, pool1	10027-101D9	146.84	31.81	0.60	0.30	10.64
thymus, fetal, pool1	10043-101F7	159.81	21.40	1.45	0.10	23.79
thyroid carcinoma cell line:KHM-5M	10776-110G2	25.40	3.46	0.66	0.93	4.25
thyroid carcinoma cell line:TCO-1	10783-110G9	35.48	2.37	1.12	0.28	5.03
thyroid, adult, pool1	10028-101E1	24.17	3.45	0.56	0.00	6.53
thyroid, fetal, donor1	10060-101H6	15.82	5.01	0.53	0.00	9.23
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	6.16	0.00	0.00	9.24
tongue, adult	10203-103F5	39.54	7.21	0.93	0.00	7.44
tongue, fetal, donor1	10059-101H5	40.20	2.76	0.00	0.00	3.15
tonsil, adult, pool1	10047-101G2	87.15	11.32	1.30	0.00	15.03
trachea, adult, pool1	10029-101E2	39.26	4.99	1.06	0.16	6.22
trachea, fetal, donor1	10058-101H4	15.77	4.62	0.77	0.00	8.08
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	36.49	2.13	0.00	0.00	9.92
transitional-cell carcinoma cell line:5637	10418-106C4	26.34	5.67	1.01	0.41	8.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	108.43	8.46	1.41	0.31	23.50
tridermal teratoma cell line:HGRT	10694-109G1	3.81	3.81	0.00	0.00	13.32
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	51.72	3.22	0.59	0.00	17.61
umbilical cord, fetal, donor1	10057-101H3	20.87	2.09	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	32.93	7.00	2.39	0.17	4.61
uterus, fetal, donor1	10055-101H1	30.72	4.10	0.51	0.00	7.68
vagina, adult	10204-103F6	25.20	5.82	1.29	0.65	8.40
vein, adult	10191-103E2	43.18	7.01	0.44	0.00	9.64
xeroderma pigentosum b cell line:XPL 17	10563-108A5	26.97	1.34	0.00	0.00	11.75